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Definitions
Nomenclature. The nomenclature used to characterize different tendon disorders has been 
confusing, at least in part because of a lack of understanding of the underlying pathology. Based 
on previous definitions described by Jozsa and Kannus 1997, Clancy 1990, Leadbetter 1992 and 
Khan et al. 1998 the following terminology is used in this thesis: 
Paratenonitis. Previously named “tenosynovitis”, “tenovaginitis” and “peritendinitis”. This is an 
inflammation of only the paratenon, either lined by synovium or not. The histopathologic 
findings consist of inflammatory cells in paratenon or peritendinous areolar tissue. The clinical 
signs and symptoms include the cardinal inflammatory signs with swelling, pain, crepitation, local 
tenderness, warmth and dysfunction. 
Paratenonitis with tendinosis. Previously named ”tendinitis”. Characterized by paratenon
inflammation associated with intratendinous degeneration. The histopathologic findings consist 
of inflammatory cells in the paratenon or peritendinous areolar tissue and loss of tendon 
collagen, fiber disorientation, vascular ingrowth, but absent or very sparse intratendinous 
inflammation. The clinical picture is the same as seen in paratenonitis, with frequently palpable 
tendon nodules, swelling and inflammatory signs. 
Tendinosis. Previously named ”tendinitis”. Intratendinous degeneration due to different etiologic 
factors characterized histologically by noninflammatory intratendinous collagen degeneration 
with fiber disorientation and vascular ingrowth. In tendinosis there is no swelling of the tendon 
sheat, and there can be a palpable tendon nodule.
Tendinitis. Previously named “tendon strain” or “tendon tear”. This is a symptomatic 
degeneration of the tendon with vascular disruption and inflammatory repair response.
Patellar tendinopathy. This term means the lesion associated with pain and tenderness at the lower 
point of the patella and lesions of the main body of the tendon. It can be used to describe both 
acute and overuse conditions, but does not assume any knowledge about the underlying 
pathology.
Jumper’s knee. A clinically defined condition with exercise-related pain localized at the quadriceps
insertion to the patella or the patellar tendon and its proximal insertion, combined with pain on 
palpation at the same localization. 
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Summary
The term “tendinopathy” describes a medical condition associated with a lesion with tendon pain 
and tenderness. It can be used to describe both acute and overuse conditions. Tendinopathy is 
assumed to be caused by overload in more or less susceptible individuals. The aim of this thesis 
was to study certain aspects of this disease in athletes with tendinopathy localized to their patellar 
tendon, and based on the findings suggest a model that can explain the relationship between a 
suspected chronic overload injury and the tissue response on macro and cellular level. 
The aim of the study presented in Paper I was to estimate the prevalence of jumper’s knee in 
different sports among female and male athletes, in order to correlate the prevalence to the
loading characteristics of the extensor mechanism in these sports. The study was designed as a 
cross-sectional study. We examined approximately 50 Norwegian male and female athletes at the 
national elite level from different sports. The examination included an interview on individual 
characteristics (weight, age, height, and training background), a clinical exam and self-recorded 
VISA score (from 0 (worst) to 100 (best). The overall prevalence of current jumper’s knee was 
14.2% (87 of 613 athletes), with a significant difference between sports with different 
performance characteristics (range: 0-45%). In addition, 51 athletes (8%) reported previous 
symptoms. The prevalence of current tendinopathy was lower among women (5.6±2.2%) 
compared with men (13.5±3.0%; Ʒ2 test, p=0.042). The duration of symptoms among athletes 
with current tendinopathy (n=87) was 32±25 (SD) months with a VISA score of 64±19. The 
study shows that the prevalence of jumper’s knee is high in sports characterized by high demands 
on speed and power for the leg extensors. The symptoms are often serious, resulting in long-
standing impairment of athletic performance. 
In Paper II we assessed the ultrasound characteristics of the patellar tendon in two groups of 
volleyball players, one group without knee symptoms and one group with symptoms of jumper's 
knee. Of 47 male elite players, 25 were diagnosed to have current and 7 to have had previous 
symptoms of jumper's knee, as determined by clinical examination. Since some players had
bilateral problems, there were 34 knees with current problems and 9 with previous problems. 
Seven of the 30 knees with a clinical diagnosis of jumper's knee in the patellar tendon had normal 
ultrasound findings, and ultrasound changes believed to be associated with jumper's knee (tendon 
thickening, echo signal changes, irregular paratenon appearance) were observed in 12 of 51 knees 
without symptoms. Specific ultrasound findings such as paratenon changes, hypoechoic zones or 
pathologic tendon thickness proximally did not correlate significantly with the degree or the 
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duration of symptoms. This study suggests that the specificity and sensitivity of ultrasonography 
is low in the evaluation of patients with mild symptoms of jumper's knee. 
In Paper III and IV, we examined the biomechanical characteristics of the extensor mechanism 
in athletes with jumper’s knee compared with healthy controls, and described their training 
background and body characteristics.
In Paper III, patient and control groups (12 players in each) were selected from a population of 
141 well trained male Norwegian volleyball players, of which 55 (39%) satisfied the diagnostic
criteria for jumper's knee. The testing program consisted of a standing jump (SJ), a counter-
movement jump (CMJ), a 15 second rebound jump test (RJ), a standing jump with a 20 kg load 
(SJ20 kg) and a load corresponding to one-half body weight (SJ1/2 bw). The test result of the patient 
group was significantly higher than that of the control group for CMJ (15% increase), power
during RJ (41%), work done in SJ (12%) and CMJ (22%), and the difference between CMJ and SJ 
(effect of adding eccentric component). In conclusion, athletes with jumper's knee demonstrated
better performance than healthy athletes in jump tests, particularly in ballistic jumps involving 
eccentric force generation.
In Paper IV, the purpose of the study was to examine the performance of the leg extensors in 
two groups of high level male volleyball players, one group with jumper’s knee (n=24) and a 
control group (n=23) without knee symptoms. The groups were similar in age, height and playing 
experience, but the patient group did more specific strength training and had a higher body 
weight. The testing program consisted of different jump tests with and without added load. Jump 
height was measured using a contact mat connected to an electronic timer, whereas equipment
recording load displacements was used to measure velocity, force and power during jumps with 
added load. The results showed that the patient group scored significantly higher than the control 
group on a composite jump index calculated from the individual test results.
In Paper V, we did a case-control study to examine if nerve ingrowth and altered expression of 
sensory and sympathetic neuromediators may play a major role in the pain pathophysiology of 
patellar tendinopathy, since the mechanisms behind the occurrence of cronic tendon pain is still 
largely unknown. Biopsies from the patellar tendon in patients with patellar tendinopathy were 
compared with biopsies from a control group without any previous or current knee complaints
compatible with patellar tendinopathy. The biopsies were stained immunohistochemically for 
sensory and autonomic nerve markers. With semi-quantitative methodology the biopsies from 
the two groups were compared. Chronic painful patellar tendons exhibited increased occurrence 
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of sprouting non-vascular sensory, substance P (SP)-positive nerve fibers and decreased 
occurrence of vascular sympathetic nerve fibers, positive to tyroxin hydroxylase (TH ; a marker 
for noradrenaline). Increased occurrence of SP suggests a nociceptive and maybe also a 
proliferative role in tendinopathy, while the decreased occurrence of TH may reflect a decreased 
anti-nociceptive role. Further neuro-anatomic studies should be performed for elucidating future 
specific treatment of tendinopathy.
Paper VI was a case-control study to see if an apoptotic process is part of the pathophysiology in 
tendinopathy. Apoptosis, also called “programmed cell death”, is a specific physiological 
response to different stimuli with distinct morphological and biochemical changes ending up with 
cell death. Biopsies from the patellar tendon in patients with patellar tendinopathy were 
compared with biopsies from a control group without any previous or current knee complaints
compatible with patellar tendinopathy. The presence of apoptosis was examined with 
immunohistochemical methods using a polyclonal antibody recognizing active caspase-3, 
confirmed by labeling DNA strand breaks (F7-26 antibody) and nuclear morphology. There was 
a significant higher number of apoptotic cells per unit area in tendinopathic samples compared 
with controls. Although the tendinopathic samples displayed increased cellularity, the apoptotic 
index was significantly higher. This study confirms that apoptosis is a feature of tendinosis. This 
suggests that tenocyte death may either limit the ability of injured tendon to recover from chronic 
injury, or may be involved in the ongoing repair and remodeling of the chronically injured 
tendon.
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Introduction
Introduction
Anatomy
Gross anatomy 
The patellar tendon extends from the lower patellar pole to the tibial tuberosity and is the 
extension of the common tendon of insertion of the quadriceps femoris muscle. It is about 3 cm 
wide in the coronal plane and 4-5 mm deep in the sagittal plane (Khan et al. 1998). The bulk of 
the tendon is attached to the distal two-thirds of the anterior aspect of the patella with fascicles
converging in the frontal plane and parallel in the sagittal plane towards their tibial attachments
(Basso et al. 2001). The length of tendon fascicles varies with longer anterior fascicles than the 
corresponding posterior fascicles, since the anterior bundles are attached more proximal to the 
patella and more distal to the tibia than the corresponding posterior bundles (Basso et al. 2001). 
The tendon is surrounded by a loose areolar connective tissue called the paratenon, which 
functions as an elastic sleeve and permits free movement of the tendon against the surrounding 
tissue (Kvist et al. 1985, Hess et al. 1989). Under the paratenon the tendon is surrounded by a 
fine connective tissue sheath called the epitenon which on its inner side is contiguous with the 
endotenon. This endotenon invests each tendon fiber and binds individual fibers (Hess et al. 
1989, Jozsa et al. 1991). The endotenon network allows the fiber groups to glide on each other
and to carry blood vessels, nerves and lymphatics to the deeper portions of the tendon (Hess et 
al. 1989, Jozsa et al. 1991). 
Vascular supply 
The arterial supply is from three arterial pedicles on each side of the patellar tendon. Two main 
arcades anastomose with these pedicles, the retropatellar and the supratubercular resulting in a 
peritendinous network characterized by a high vascular density next to the poles of the patellar 
tendon. The retropatellar arch has an average diameter of 1.5 mm and courses horizontally across 
the fat pad in the posterior surface of the patellar tendon and is placed at the level of junction 
between the patella and the tendon (Soldado et al. 2002). Only the retropatellar and the 
supratubercular arches give rise to vessels that pierce the tendon, which means that there are two 
vascular segments in the arterial supply of the patellar tendon (bipolar pattern). The upper 
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segment of the patellar tendon is supplied by arterioles that reach the posterior surface from the 
retropatellar arch and enter the tendon substance from the posterior side. The inferior segment is 
supplied from arterioles from superficial vessels from collaterals of the supratubercular arch.
These intratendinous vessels create anastomoses in the middle third of the patellar tendon
(Soldado et al. 2002). In the tendon substance there is an intratendinous vascular network
together with nerves and lymphatics localized to the endotenon septas (Elliott 1965, Hess et al. 
1989). This intratendinous network consists of longitudinally arranged vessels with one artery
followed by two veins. Small arterioles and capillaries originate from these longitudinally arteries 
and form the microvascular units of the tendon tissue organized to ensure an adequate 
metabolism in all part of the fiber fascicles (Ippolito 1986).
Cell components 
The cellular elements of the patellar tendon consist of 90-95% tenoblasts and tenocytes, the rest 
are chondrocytes at the insertion sites, nerve and vessel cells (Jozsa and Kannus 1997). The
morphologic features of young tenoblasts support the concept that these cells have a high 
metabolism with high synthesis of the matrix components (Jozsa and Kannus 1997). The tendon 
cells have the enzyme chains for all of the main pathways of energy metabolism: the Krebs cycle, 
anaerobic glycolysis and the pentose phosphate shunt (Ippolito 1986, Jozsa et al. 1979). 
Innervation
The patellar tendon is innervated mainly by sensory nerves entering the tendon substance via the 
endotenon septa. Inside the tendon the nerves are relatively few in number and follow the 
vascular channels, anastomise with each other and finally terminate in the sensory nerve endings 
(Ippolito 1986, Jozsa et al. 1993). However, the innervation within the patellar tendon and the 
distribution of the different nerve fiber types within the patellar tendon substance is mostly 
unknown.
In tendon tissue in general the myelinated A-fibers innervate specialized multicellular end organs 
with high sensitivity to mechanical stimuli (Bray et al. 2005). The mechanoreceptors found in 
tendons and ligaments are important in motor control (Proske et al. 1988). The different kinds of 
free nerve endings, called nociceptors, are activated by mechanical, chemical and thermal stimuli 
and can be sensitized by repetitive activation (Schepelmann et al. 1992). Stimulation of these 
nociceptive fibers results in vasodilatation, increased vascular permeability and oedema, which is 
called “neurogenic inflammation” (Bayliss 1901, Lewis 1937). The autonomic nerve fibers are 
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mainly localized in networks around blood vessels in the epiligaments and loose connective tissue 
around the tendons and ligaments (Bray et al. 2005). Both sympathetic and parasympathetic
autonomic fibers have been identified in tendons and ligaments (Bray et al. 2005). According to 
Bray et al. (2005), there are three groups of neurotransmitters of importance in the regulation of 
tendon and ligament physiology; sensory, opioid and autonomic according to their function and 
original nerve fiber type. They can act as neurotransmitters, hormones and paracrine factors.
Sensory neuropeptides with nociceptive and pro-inflammatory effect are substance P (SP) and 
calcitonin gene-related peptide (CGRP) (Ziche et al. 1990). These neurotransmitters are found in 
pain-transmitting C-fibres (Gibson et al. 1984, Lembeck et al. 1987, Wiesenfeld-Hallin et al. 
1984). Substance P is involved in a multitude of physiological processes due to its widespread 
distribution, centrally and peripherally; among them are angiogenesis and vasodilatation
(Konttinen et al. 1990). The autonomic nerve system can influence the sensory C-fibers by 
sensitizing or desensitizing the pain receptors. 
Physiology
Tendons are extremely strong with an ultimate failure-stress range of 56.7±4.4 MPa (Stanish et al. 
1985). According to Stanish et al. (1985), tendons may be subject to fatigue with high chronic 
repetitive loading, despite the fact that the cyclical loads may be well within the tendons ultimate
failure-stress range. Physiological loads usually cause less than 4% increase in the length of the 
tendon and strain above 4% results in damage to one or more of the tendon fibre bundles, while 
strain in excess of 8-12% results in complete tendon rupture (strain is calculated as change in 
length per unit length) (Elliott 1965, Jozsa and Kannus 1997, Burstein and Wright 1994). It has 
been estimated that forces within the patellar tendon may reach 14.5 kN during competitive 
weight lifting resulting in a total patellar rupture, which corresponds to more than 17.5 times the 
lifter’s body weight (Zernicke et al. 1977). When calculated per cross-sectional area, there is no 
gender difference in the tensile strength of human tendons (Becker and Krahl 1978). Forces that 
place highest stress on the tendon occur during eccentric muscle contraction (Fyfe and Stanish 
1992, Stanish et al. 1985). The maximal muscle force that can be generated eccentrically is 1.5-2.0 
times higher than the maximal isometric force, and several-fold higher than maximal concentric
force, especially at high speeds (Herzog 2000). Also, the ground reaction force is different 
between different tasks, ranging from 2.8 times body weight during distance running to 6 times 
body weight during jumping in volleyball and 10 times body weight in a long jump take off 
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(McNitt-Gray 2000). The highest ground reaction forces are seen with ballistic drop jumps, and 
the resulting forces through the extensor tendons are proportional to the ground reaction force.
In a study by Basso et al. (2002), they found that under quadriceps loading there was significantly 
higher strain in the posterior fascicles compared with the anterior fascicles between 60 and 90 
degrees of knee flexion. The material properties in the anterior and posterior fascicles were 
similar, except that the failure strain was significantly higher posterior. For a same amount of 
elongation, the shorter posterior fascicles strain more than the longer anterior fascicles. This 
could mean that the posterior fascicles are adapted to sustain significantly greater tensile strain 
before failing (Basso et al. 2002). However, in a recent study by Almekinders et al. (2002), they 
found that the strain increased on the anterior side but decreased on the posterior side in the 
central, proximal location of the tendon in dynamic measurements in the range from 0 to 60 
degrees of flexion. The cross-sectional area of the tendon increases from proximal to distal (el-
Khoury et al. 1992). Since shear stress is directly correlated to the cross-sectional area, the shear 
stress can therefore be assumed to be higher in the proximal part of the tendon compared with 
the distal part.
Pathology
Histopathology
The histopathological findings in biopsies from the patellar tendon in patients with tendinopathy
are very consistent. Under light microscopy the biopsies are characterized by degeneration and 
fibrotic scarring in the tendon itself, as well as in the bone-tendinous junction (Ferretti et al. 1985, 
Fritschy and de Gautard 1988, Kälebo et al. 1991, Myllymäki et al. 1990, Orava et al. 1986, 
Raatikainen et al. 1994, Roels et al. 1978). The normal parallel collagen bundles are disorganized 
and replaced by degenerative tissue with increased ground substance, consisting of proteoglycans
and glycosaminoglycans (Khan et al. 1996). The tenocytes lose their spindle shape and nuclei
appear more rounded (Clancy 1990). There are an increased number of fibroblasts compared
with normal tendons (Ferretti et al. 1983, Colosimo and Bassett 1990, Fritschy and deGautard 
1993, Roels et al. 1978, Martens et al. 1982). There is also neovascularization with capillary
proliferation and prominent angiogenesis (Roels et al. 1978, Colosimo and Bassett 1990, Khan et 
al. 1998). There are clefts in the collagen bundles, which have been assumed to represent 
microscopic tears in the tendon substance (Roels et al. 1978, Davies et al. 1991, Kujala et al. 
1989, Raatikainen et al. 1994). In a recent presentation, Maffulli et al. (2005) reported similar 
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histopathological findings in tendinopathic Achilles and patellar tendons. They stated that “a 
common, as yet unindentified, etiopathological mechanism may have acted on both these tendon 
populations.” This means that there may be a common pathophysiological pathway that may 
explain the very uniform histopathological findings in tendinopathic tissue biopsies. 
One of the most striking findings is the absence of inflammatory cells. As stated by Khan et al. 
(1998), there are two papers coauthored by specialist pathologists who report a total absence of 
inflammatory cells in tissue from patients with jumper’s knee, even at the periphery of abnormal 
tissue and in patients who had symptoms for only four months (Yu et al. 1995, Khan et al. 1996). 
In a study by Alfredsson et al. (2003), they used cDNA arrays and real-time quantitative 
polymerase chain reaction technique to study tendinosis and control tissue samples and found 
that several cytokines and cytokine receptors were not upregulated, indicating the absence of an 
inflammatory process in chronic painful Achilles tendinosis.
Cell pathology
However, one consistent finding in biopsies from tendinotic tissue is hypercellularity. In the 
absence of inflammatory cells, the hypercellularity must be explained by the presence of other cell 
types. These cells are not fully characterized.
Recently, it has been suggested that the initial pathology in tendinopathy is to the tenocyte, not 
the collagen fibres (Khan et al. 2000b, Yuan et al. 2003, Cook et al. 2004). Necrosis and apoptosis 
are the two major types of cellular death (Ameisen 1996, Lavin and Watters 1993, Sen 1992). 
Necrosis is characterized by rupture of the cell membrane and very often an inflammatory 
response and a pathological tissue reaction involving groups of adjoining cells (Ameisen 1996).
Apoptosis, also called “programmed cell death,” is a specific physiological response to different 
stimuli with distinct morphological and biochemical changes ending up with cell death, very often 
without a concomitant inflammatory response (Lavin and Watters 1993, Sen 1992). The 
apoptotic process is stimulated and inhibited by a number of influencing factors, such as 
hormones, cytokines and growth factors (Kiess and Gallaher 1998). At the cellular level the 
tendon cells are also influenced by mechanical factors, such as repetitive loading and stretching 
(Skutek et al. 2003, Barkhausen et al. 2003, Arnoczky et al. 2002). In a study by Yuan et al. (2002), 
they found excessive apoptosis at the edge of torn rotator cuff tendons compared with controls. 
However, in this study the mean age of the patients was more than 60 years and they had a 
rupture of the rotator cuff. Tendon rupture may result from a different pathological process 
compared to tendinosis. This means that the findings by Yuan et al. (2002) cannot necessarily 
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explain the pathology found in tendinopathic tissue biopsies. In a study by Scott et al. (2005) they 
showed that apoptosis could occur in response to short term, high strain mechanical loading in a 
rat tibialis anterior model. This means that there is evidence for a connection between mechanical 
factors and apoptosis both at the cellular level and at the isolated tendon level. These findings 
suggest that apoptosis may be a factor in tendon overload injuries. However, it is still unknown
whether there is a connection between mechanical factors and apoptosis in vivo in humans. This 
problem was explored in Paper VI. 
Vascular pathology
Another consistent histopathological finding in tendinotic tissue biopsies is neovascularization 
with capillary proliferation and prominent angiogenesis (Roels et al. 1978, Colosimo and Bassett 
1990, Khan et al. 1998). This neovascularization may be a part of the remodeling process, but is 
assumed to weaken the mechanical stability by proteolysis of the extra-cellular matrix by the 
invading endothelial cells (Petersen et al. 2004b). Angiogenesis is controlled by many stimulatory
and inhibitory proteins acting on invading endothelial and smooth muscle cells (Ferrara 1999). 
One of the most important angiogenetic factors is vascular endothelial cell growth factor 
(VEGF) (Senger et al. 1983). High VEGF concentrations have been demonstrated in 
degenerative tendon tissue compared with healthy Achilles tendons (Pufe et al. 2001, Petersen et 
al. 2004a). In response to VEGF stimulation vascular and smooth muscle cells produce matrix 
metalloproteinases (MMPs) (Wang and Keiser 1998, Sato et al. 2000). The protease inhibitor
tissue inhibitor of metalloproteinase-3 (TIMP-3) blocks VEGF from binding to its receptor
VEGFR-2, thereby reducing the effect of VEGF (Qi et al. 2003). This means that there are 
interactions between VEGF and MMPs and TIMPs resulting in weakened material properties in 
the tendon in degenerative tendon disease (Pufe et al. 2005). Another regulatory pathway of 
VEGF production is by the transcription factor hypoxia inducible factor-1 (HIF-1). VEGR is 
upregulated by HIF-1, and HIF-1 is upregulated by hypoxia (Maxvell  et al. 2001, Ferrara 1999). 
In a study by Petersen et al. (2004b), they found that mechanical stress induced HIF-1 and 
VEGF in isolated tendon cells. This means that both hypoxia and mechanical factors influence 
the expression of VEGF. The role of VEGF and HIF-1 in the angiogenetic process seen in 
biopsies from patients with patellar tendinopathy is not known.
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Healing processes
The reparative processes in tendinosis are also poorly understood. Whether tendinosis is a 
primary degenerative condition, or if there are simultaneous degenerative and reparative 
processes within the tendon substance is unknown. Many growth factors and matrix molecules 
with different biological effects can be found in the tendon substance with different temporal
expression (Dahlgren et al. 2005). Both insulin-like growth factor-1 (IGF-1) and transforming 
growth factor ß1 (TGF-ß1) are produced by tenoblasts, and in vitro these two growth factors 
increase cell proliferation and the synthesis of collagen and proteoglycans (Abrahamsson et al. 
1991, Letson and Dahners 1994, Tsuzaki et al. 1994). Whether these growth factors are up-
regulated in tendinotic tissue is not known. If there is an increased expression of IGF-1, this may, 
at least in part, explain the hypercellularity found in biopsies from tendinotic tissue. An increased
expression of IGF-1 would also indicate an ongoing reparative process within the tendon tissue.
Pain mechanisms 
In the absence of inflammatory cells, the substrate for pain production is confusing. In biopsies 
from degenerated facet joints and degenerated intervertebral discs it has been shown that there is 
in-growth of nociceptive nerve fibers (Freemont et al. 1997, Coppes et al. 1997, Konttinen et al. 
1990). It is not known whether this is part of the pain mechanism in tendinopathy. In a study by 
Bjur et al. (2005), they examined the innervation pattern of the normal and tendinotic Achilles 
tendon and found SP and CGRP in the paratendinous loose connective tissue and to some extent 
in the tendon tissue proper intimately associated with small blood vessels. However, as described 
earlier, the innervation and distribution of the different nerve fiber types within the patellar
tendon substance is unknown. The pain mechanisms in patellar tendinopathy are also mostly 
unknown. These issues were the focus of Paper V. 
Diagnosis of patellar tendinopathy 
The diagnosis of jumper’s knee is based on a history of pain localized to the lower patellar pole 
or insertion of the quadriceps tendon in connection with athletic activity and distinct palpation
tenderness corresponding to the painful area (Blazina et al. 1973). The diagnosis of patellar 
tendinopathy requires that, in addition to a typical history and clinical signs, there are structural 
changes in the tendon, as demonstrated by MR, ultrasound or tendon biopsies. Nevertheless, in 
the clinical setting the diagnosis is often based on a typical history and clinical findings alone. 
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In fact, when the current research projects were started, the relationship between imaging
findings and symptoms had not been clarified. Previously the diagnostic precision by use of 
ultrasound was assumed to be high, since several studies had shown a near-perfect correlation 
between preoperative ultrasound changes and surgical findings (Raatikainen et al. 1994, Orava et 
al. 1986, Kälebo et al. 1991, King et al. 1990, Karlsson et al. 1992). However, as these studies
were carried out in a selected patient group (i.e. almost all of them had disabling symptoms who 
did not respond to non-operative treatment), the results should be interpreted carefully when 
applied to other patient populations. 
The only previous study comparing the clinical and ultrasound-based diagnosis of jumper's knee 
was done by Myllymäki et al. (1990). Of 62 knees with characteristic symptoms of jumper's knee, 
they reported no hypoechoic changes in 31 (50%). However, to our knowledge, there is no 
available information on the histopathological changes in patients with Roels' grade I, II or IIIa 
disease. In spite of lack of this information, attempts had been made to correlate ultrasound
changes and anatomical findings to the clinical staging of the disease (Fritschy and DeGautard
1988, Jerosch et al. 1990). Jerosch and Schröder (1990) suggested that a relationship exists 
between the severity of the pathological changes and certain ultrasound characteristics. However, 
their study did not include corresponding histopathological examinations, which means that their 
conclusions were based on assumptions. In Paper II, we have examined the ultrasound 
characteristics of the patellar tendon among high-level volleyball players with and without
jumper’s knee. 
To assess the severity of the disease Roels' clinical grading system (Roels et al. 1978) has been 
used. It is assumed that this grading system reflects the clinical seriousness of the disease, but the 
system is based more on clinical experience than research. In describing patients with jumper's
knee, we proposed a modification to Roels' clinical grading system. There are several patients 
who are able to play matches and practice despite having pain throughout the activity, but for 
whom there is no available classification category according to Roels et al. (1978). We therefore 
suggested splitting grade III into grade IIIa for patients with pain during activity, but who are still 
able to train and play matches, and grade IIIb for those with disabling pain (Table 1). This 
modification would enable a more precise patient classification in future epidemiological and 
clinical studies. 
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Table 1. Classification of jumper's knee according to symptoms as outlined by Roels et al. (1978) as modified by us.
Roels et al. (1978) Our classification
Grade I Pain at the infrapatellar or suprapatellar 
region after practice or after an event 
Same
Grade II Pain at the beginning of the activity, 
disappearing after warm-up and
reappearing after completion of activity
Same
IIIa: Pain during and after activity, but the
patient is able to participate in sports at the 
same level 
Grade III Pain remains during and after activity
and the patient is unable to participate in 
sports
IIIb: Pain during and after activity and the 
patient is unable to participate in sports at the 
same level 
Grade IV Complete rupture of the tendon Same
In order to assess the severity of the condition, athletes diagnosed with patellar tendinopathy can 
self-record their VISA score (Visentini et al. 1998). This is a validated pain and function score 
with a best score of 100 (no symptoms) and lowest score of 0 (maximum symptoms), which has 
been developed specifically for this purpose and has been shown to be a valid measure of 
symptoms (Robinson et al. 2001). 
Epidemiology of jumper’s knee 
The prevalence of jumper’s knee across different sports is mostly unknown. However, early
studies from volleyball have shown that among male players at the elite level the prevalence is 40-
50 % (Ferretti et al.1983, Ferretti et al. 1990). Publications from studies on the outcome after 
surgery suggest that the prevalence may be high in sports with high demands on speed and
power, such as volleyball, soccer and athletics (Karlsson et al. 1991, Raatikainen et al.1994, 
Martens et al. 1982). Raatikainen et al. (1994) from Finland described 182 patients undergoing 
surgery for jumper’s knee and found that 46% were from athletics, 37% from volleyball, 5% 
from soccer and the rest from other sports. On the other hand, Martens et al. (1982) from 
Belgium found that only 8% of his 90 surgically treated patients were from athletics, while 34% 
were volleyball players and 32% soccer players. Furthermore, Karlsson et al. (1992) from Sweden 
reported that of 81 patients they treated for jumper’s knee, only 9% were volleyball players, while 
37% were from athletics and 27% from soccer. In all of the three studies described, basketball 
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accounted for less than 10% of patients. As illustrated by the conflicting results from these 
(Karlsson et al. 1992, Raatikainen et al. 1994, Martens et al. 1982) and other studies (for a 
complete review of surgical studies, see Coleman et al. 2000), is not possible to estimate 
prevalence from case series, since the population at risk is unknown. The differences observed in 
the proportion of patients from different sports may simply reflect how popular these sports are 
in the different countries. To our knowledge, there are no previous reports on the prevalence of 
jumper’s knee across different sports, nor is the severity and duration of symptoms well
described across sports. This issue was therefore examined in Paper I. 
Intrinsic risk factors for patellar tendinopathy 
In general, risk factors for sports injuries are traditionally divided into internal, personal, risk 
factors and external, environmental, risk factors which can act either alone or in combination
(Lorentzon 1988, Stanish 1984, van Mechelen et al. 1992). In tendon overuse injuries, an 
interaction between these two categories is common (Harvey 1983, Williams 1986).
According to Hess et al. (1989), almost any orthopaedic disorder that causes a variation from 
normal anatomic position and resulting vector forces on a tendon may cause an overuse 
syndrome. The most common intrinsic factors suggested in tendon overuse injuries are said to be 
alignment abnormalities, leg length discrepancy, muscle weakness and imbalance, decreased
flexibility, joint laxity, gender, age, overweight and predisposing diseases (Hess et al. 1989, Micheli 
1983, Renström 1988, Heiser et al. 1984, Kannus et al. 1987, Drinkwater 1988). Most of these 
references are review articles and none of them specifically address patellar tendinopathy. As 
stated by Lorentzon (1988); in general, it should be stressed that this area is highly conjectural 
and that many plausible hypotheses lack substantial evidence. It is claimed that in elite athletes a 
leg length discrepancy of more than 5 to 6 mm may cause symptoms (Michaeli 1983, Renström
1988). However, the clinical significance of leg length discrepancy is uncertain and further 
investigations in athletes providing substantiating data are needed before any firm conclusions 
can be drawn (Lorentzon 1988). Muscle imbalance means that there is an asymmetry between the 
agonist and the antagonist muscles in one extremity, asymmetry between the extremities, or a 
difference with an anticipated normal value (Grace 1985). The actual magnitude of what 
constitutes balance and imbalance has never been accurately defined and may actually be
dependent on anatomic region involved, type of sport, age, size and gender (Grace 1985). There 
is some evidence that certain conditioning programs can reduce the injury rates related to muscle 
weakness or imbalance (Heiser et al. 1984), but other studies could not find any relationship 
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between muscle weakness or imbalance and injury (Grace 1985). As far as we know, there are no 
studies investigating the connection between patellar tendinopathy and muscle imbalance. 
Moreover, there are no studies to provide conclusive evidence on whether reduced flexibility is 
the cause or the consequence of tendon injuries (Jozsa and Kannus 1997).
Gender
According to Kannus et al. (1987) and Drinkwater (1988), there is a higher incidence of tendon 
overuse injuries among females compared with men. Women have less muscle mass per unit 
body weight than equally trained men, and their overall muscle strength averages about two-
thirds that of men (Drinkwater 1988). Jozsa and Kannus (1997) suggest on a theoretical basis that 
these factors together with female risk factors in body anatomy and biomechanics (i.e., wider hips 
and more mobile joints) may predispose women to overuse injuries. Ferretti (1986) also 
presented the results from a sample of 26 volleyball players selected from 93 players diagnosed 
with jumper’s knee in a random cohort of 407 volleyball players participating in the Italian 
Volleyball Championship. The selection criteria were not described and there was no control
group. They found no difference in the prevalence of jumper’s knee between males and females. 
In other words, there is limited epidemiological evidence to substantiate the claim for a gender 
bias in overuse tendon injury risk. This issue was studied in Paper I. 
Antropometric data, strength and flexibility
Data on intrinsic factors for patellar tendinopathy are conflicting, and mostly related to static 
biomechanical characteristics (Ferretti et al. 1984, Kujala et al. 1986, Kujala et al. 1987). In a study 
by Hunter and Pole (1987), they suggest that “patellar tendinitis” can be caused by tight 
hamstring and quadriceps muscles and treated by flexibility training. However, this study does 
not give any information on flexibility measurements or specific outcome measures to support 
their suggestions.
In a study by Witvrouw et al. (2001), they followed 138 students without any knee complaints at 
inclusion for two years. At inclusion all students were evaluated for leg alignment characteristics,
muscular tightness, and muscular strength. The leg length alignment characteristics were obtained 
by clinically measuring the leg length discrepancy, Q-angle and the medial tibial intercondylar 
distance. Isokinetic strength of the quadriceps and hamstring muscles were evaluated on a 
dynamometer. The tightness of the hamstrings and quadriceps femoris muscles were measured 
goniometrically. Nineteen of these 138 students developed “patellar tendonitis” based on clinical 
11
Introduction
and ultrasonographic examinations. Univariate and stepwise discriminant function analysis were 
performed on different measurements, and the only significant factor was muscular flexibility, 
with the patellar tendonitis patients being less flexible in the quadriceps and hamstring muscles 
(p< 0.05). To explore this issue, stretching and warm-up habits were compared between athletes 
with jumper’s knee and controls in Paper III and IV. 
In a study by Ferretti et al. (1984) among 407 male volleyball players they found a small peak in 
incidence between 20 and 25 years and an incidence peak at the third year of play, but concluded
that age and years of play were not significant factors in producing jumper’s knee. Age and years 
of play as intrinsic predisposing factors are examined in Papers I, III and IV.
In another study by Ferretti et al. (1983), primarily on histological findings in biopsies from 
athletes with jumper’s knee, they also report that out of 18 knees treated surgically, two patients 
had patella alta and eight had a vastus medialis obliquus dysplasia. However, none of these
patients were characterized further in the text, and the diagnostic criteria used were not 
described.
Ferretti (1986) also presented the results from a sample of 26 volleyball players selected from 93 
players diagnosed with jumper’s knee in a random cohort of 407 volleyball players participating in 
the Italian Volleyball Championship. The selection criteria were not described and there was no 
control group. Evaluation of the knee alignment, alignment of the extensor mechanism, position 
of the patella, characteristics of the tibial tuberosity, rotation of the femur, rotation of the tibia, 
degree of constitutional instability, characteristics of the foot or morphotype, did not give 
conclusive results with regard to predisposing intrinsic factors.
Leg length and patellar position 
In the same study by Ferretti (1986) they assessed the position of the patella both clinically and 
radiographically using the method of Insall and Salvati (1971), and concluded that the patella was 
“slightly high” in four out of 26 athletes diagnosed with jumper’s knee. However, they did not 
specify whether this finding was based on clinical or radiographic methods, or both.
In contrast, in a series of papers by Kujala et al. (1986, 1987, 1989) they found more leg length 
inequality and patella alta in patients with jumper’s knee compared to controls. They compared
20 athletes diagnosed with jumper’s knee with a control group of 20 athletes with normal knees 
and found a significantly higher mean value for lower leg length inequality in the athletes with 
jumper’s knee compared with the control group (7.3 mm ± 4.2 mm vs. 3.0 mm ± 2.3 mm, 
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p<0.001) (Kujala et al. 1986). In the same study, they measured patellar height using two different 
methods. The Insall-Salvati method relates the length of the patellar tendon to the length of the 
patella (Insall and Salvati 1971), while the method described by Blackburne and Peel (1977) 
measures the ratio between the shortest distance from the distal end of the articular surface of 
the patella and the tibial plateau to the length of the articular surface of the patella. Using the 
Insall-Salvati method they found a significantly higher position of the patella in the patient group, 
but no significant difference with the Blackburne-Peel method. It should be noted that in this 
study 13 of the 20 athletes in the patient group were volleyball players, while only four out of 20 
in the control group were volleyball players, which reduces the validity of this study. In a later 
study they used radiographic methods and found that the leg length inequality among athletes
diagnosed with jumper’s knee to be 5.8 ± 4.5 mm compared to 3.0 ± mm in a control group 
(Kujala et al. 1987). In this cohort of 57 athletes with jumper’s knee there were 37 volleyball 
players, three basketball players, four long distance runners and five orienteerers. Ten athletes 
were not characterized with regard to type of activity. In the athletes with jumper’s knee the 
injury was located on the side with the longer leg in 17 of 27 (63%) of cases. The same group of 
athletes had the injury located to the takeoff leg in 30 cases and on the other side in 18 cases. 
Those who could determine their take-off leg when jumping and whose lower leg inequality was 
at least 5 mm, the takeoff leg was the longer in 15 cases and the shorter leg in seven cases. 
However, they provided no information on the connection between types of sport or takeoff 
technique, nor whether these were statistical significantly differences. 
In a final study by the same group (Kujala et al. 1989), they studied the extensor mechanism in 32 
male competitive volleyball players and a control group of 49 young males. In this study they 
used both the Insall-Salvati index and the Blackburne-Peel index to evaluate the height of the 
patella, and concluded that there was a slight, but significant (p<0.05) tendency to patella alta 
according to the Blackbourne-Peel index, but no difference based on the Insall-Salvati index. In 
this study the control group was selected from volunteers at the beginning of their military 
service, making selection bias possible. The internal validity in this study is substantially reduced 
since the control group was not representative with regard to other known factors that could 
render them susceptible to jumper’s knee. As a conclusion, based on this series of studies, there 
are conflicting results on the relationship between patella alta and jumper’s knee. However, a 
methodological limitation with these studies is the fact that the patient group and the control
group were from different sports. In this thesis, the position of the patella was examined in Paper 
II, using the Insall-Salvati index, comparing athletes with patellar tendinopathy with controls
from the same sport and with identical training background.
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In all of the previous studies described, the main study focus was on static biomechanical
parameters. In Paper III and IV we have examined dynamic characteristics of the extensor 
mechanism, which may have a stronger effect as predisposing internal factors since they reflect 
the loading pattern during training and competition.
Patellar impingement 
Johnson et al. (1996) postulated that impingement of the inferior patellar pole against the patellar 
tendon during knee flexion is responsible for “patellar tendonitis”. They studied 24 patients 
diagnosed with patellar tendonitis and concluded that there was impingement of the inferior 
patellar pole against the patellar tendon by examining the involved knee in a position of 60º of 
flexion. In this study they were able to demonstrate kinking between the patella and the patellar
tendon, but the reproducibility of their positioning protocol was questioned by the authors 
themselves. In another study by Schmid et al. (2002), they examined 19 knees diagnosed with 
patellar tendinopathy with positive MRI findings and a typical history and clinical findings. The 
control group was 32 asymptomatic knees. They obtained dynamic sagittal images from full 
extension to 100º of flexion with and without activation of the quadriceps muscle and measured 
the tendon-patella angle, anteroposterior diameter of the tendon, signal-to-noise ratio, the shape 
of the inferior patellar pole and the location of the patellar tendon insertion. They found no 
significant difference between the groups of the tendon-patella angle at any angle, with or 
without quadriceps muscle activation. The insertion site of the patellar tendon differed 
significantly with a more posterior insertion being more common in symptomatic knees, but not 
the shape of the inferior pole of the patella. The volume and the signal -to-noise ratio of zones of 
increased intratendinous signal, as well as the anteroposterior diameter of the proximal patellar 
tendon were increased in symptomatic knees. The conclusion of this study was that the data
could not support the theory that patellar tendinopathy is caused by patellar impingement,
because no difference was detected between symptomatic and asymptomatic knees. In this study, 
the MR examination protocol differed from the protocol used by Johnson et al. (1996), since the 
images were obtained through a larger range of motion, with a larger number of measurements at 
different angles of knee flexion with and without activation of the quadriceps muscle. This means 
that the study protocol in the study by Schmid et al. (2002) is more valid with regard to the 
problem they investigated in these studies. 
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Extrinsic risk factors for patellar tendinopathy 
Extrinsic predisposing factors act externally on the human body (Nigg 1988). The most common 
extrinsic factors are thought to be training errors, excessive loads on the body, poor 
environmental conditions and poor equipment (Nigg 1988, James et al. 1978, Renström and 
Johnsen 1985, Smart et al. 1980, Ferretti et al. 1984). Training errors are assumed to contribute to 
60 to 80% of tendon and other overuse injuries (James et al. 1978, Renström and Johnsen 1985, 
Smart et al. 1980), and the main problems are thought to be too high intensity and too fast
progression. And as stated by Leadbetter (1992), a sport injury is likely to occur when the athlete 
changes the mode or use of the involved part of the body. This is called “the principle of 
transition”. However, most papers on this subject are theoretical assumptions and mostly related 
to running injuries. 
Training load 
In one of the previously described studies by Ferretti et al. (1984), they examined 407 volleyball 
players from different playing levels and found the overall prevalence of previous or current 
symptoms of jumper’s knee to be 23% (74 men and 19 women). Of those athletes playing five 
times a week or more, the prevalence was 41%. There was a near linear relationship between the 
prevalence of jumper’s knee and the number of weekly training and playing sessions. However, 
they did not find any significant correlation between career duration and the prevalence of
jumper’s knee. 
Floor hardness 
The ground reaction forces during landing and take-off can be quite different on different 
surfaces. The impact force or the force at first contact is much higher for running on asphalt
compared with running on grass or sand (Nigg 1988). The ground reaction force is at the same 
magnitude for those different surfaces, and it is therefore speculated that these high-impact 
forces are one of the causes of overuse injuries (Nigg 1988). Ferretti et al. (1984) found that 
60.7% of the players with jumper’s knee played on a cemented or linoleum floor, while only 4.7% 
of those diagnosed with jumper’s knee played on a parquet floor, suggesting a positive correlation 
between the hardness of the floor and the prevalence of jumper’s knee among volleyball players. 
In line with this, it has recently been shown that the prevalence of jumper’s knee among elite 
beach volleyball players playing on sand is only 9%, considerably lower than for indoor volleyball
players (Bahr and Reeser 2003). 
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As stated previously, the ground reaction force is 6 bw during jumping in volleyball and 10 bw in 
a long jump take-off (McNitt-Gray 2000). The highest ground reaction forces are seen with 
ballistic drop jumps, and the resulting forces through the extensor tendons are proportional to 
the ground reaction force. This may explain the correlation between the number of weekly 
training sessions and the prevalence of jumper’s knee as shown by Ferretti et al. (1984). Other 
predisposing external factors for jumper’s knee than hardness of the floor and number of weekly 
training sessions have not been examined.
Methodological considerations 
From a methodological point of view, predisposing factors for overuse injuries are traditionally 
divided into external and internal factors. However, this model is unidimensional and does not 
take into account the dynamic interactions between different risk factors. As stated by Bahr et al. 
(2003), there is also a need to identify the mechanisms by which the injuries occur, and to
consider the temporal dimension in a dynamic multicausal model. One such model is described 
by Meeuwisse (1994). 
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Intrinsic risk factors:
• Age
• Gender
• Body composition (e.g.
body weight, fat mass,
BMD, anthropometry)
• Health (e.g. history of
previous injury, joint
instability)
• Physical fitness (e.g.
muscle strength/power,
maximal O2 uptake, joint
ROM)
• Anatomy (e.g. alignment,
intercondylar notch
width)
• Skill level (e.g. sport-
specific technique,
postural stability)
Predisposed
athlete
INJURY
Exposure to extrinsic
risk factors:
Risk factors for injury
(distant from outcome)
Injury mechanisms
(proximal to outcome)
Susceptible
athlete
INJURY
• Human factors (e.g. team
mates, opponents, referee)
• Protective equipment (e.g.
helmet, shin guards)
• Sports equipment (e.g. skis)
• Environment (e.g. weather,
snow & ice conditions, floor
& turf type, maintenance)
Inciting
event
• Joint motion (e.g.
kinematics, joint
forces & moments)
• Playing situation
(e.g. skill
performed)
• Training program
• Match schedule
Figure 1. A dynamic, multifactorial model of sports injury etiology as presented by Meeuwisse (1994) and modified by Bahr 
and Holme (2003) and Bahr and Krosshaug (2005). 
This model was mainly developed to describe the etiology of acute injuries. Meeuwisse (1994) 
states that it is the presence of both intrinsic and extrinsic risk factors that renders the athlete
susceptible to injury, but that these factors are not necessarily sufficient to produce injury. In his 
model the risk factors define a specific predisposition to injury, but there has to be a final inciting 
event to result in an injury. A specific final event can usually not be identified in the case of 
overuse injuries, such as patellar tendinopathy. The onset of symptoms is typically gradual and 
the pathological processes within the tissue may even start a long time before symptoms occur. 
Therefore, in overuse injuries it may be necessary to study more distant etiological factors to 
establish a basic understanding of the early pathological processes and in that way be able to 
establish prophylactic and treatment procedures. Thus, the conceptual model by Meeuwisse
(1994) cannot be applied directly to explain the etiology of overuse injuries, but has to be 
modified to characterize the etiologic factors for overuse injuries. This is highlighted by Bahr and 
Krosshaug (2005), who emphasize the need to use a comprehensive model, which accounts for 
the events leading to the injury situation as well as to include a description of whole body and 
joint biomechanics at the time of injury. In their model different intrinsic and extrinsic factors 
affect load and load tolerance, and can be used to study the interaction between the different 
factors causing injury (Bahr and Krosshaug 2005). They state that the key point to consider with 
regard to biomechanical factors is that they must explain how the event either resulted in a 
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mechanical load in excess of that tolerated under normal circumstances or reduced the tolerance 
levels to a point at which a normal mechanical load cannot be tolerated (Bahr and Krosshaug 
2005, Mcintosh 2005). 
However, the connection between a biomechanical load and the biologic response at the cellular 
level within the tendon substance is poorly understood. This connection is suggested by Khan et 
al. (1998), who have described a theoretical model on how tendon injury may precipitate a vicious 
cycle (“tendinosis cycle”) of further injury, modified from Leadbetter (1992). In this model he 
suggests that an increased demand on the tendon causes microdamage with inadequate repair 
resulting in inadequate collagen and matrix production. In turn, this results in tenocyte death
from excessive strain with further reduction in collagen and matrix production and a 
predisposition to further injury (Khan et al. 1998). In this model the tendon loading conditions 
can be regarded as an extrinsic inciting event, and Khan et al. (1998) suggests that there is a 
correlation between tendon overload and a pathologic response on the cellular level with 
tenocyte death. Interestingly, he even suggests that susceptible tenocytes may die as a result of 
excessive strain. In other words, he hypothesizes that there is a connection between a defined
biomechanical loading of tendons (strain) and a physiological well-defined response, namely
cellular death.
However, all these models are theoretical, and there is an obvious need for specific studies to 
establish evidence-based models. The overall aim of the present thesis was to examine potential
risk factors for patellar tendinopathy and to examine some of the possible cellular responses to 
these risk factors. 
Study aims
Based on the literature outline provided above, the aims of this thesis were as follows: 
1. To estimate the prevalence of jumper’s knee in different sports, in order to correlate the 
prevalence to the loading characteristics of the extensor mechanism in these sports and to 
assess the duration and severity of the symptoms (Paper I). 
2. To investigate if there is a gender difference in the prevalence of jumper’s knee (Paper I). 
3. To compare anthropometric characteristics as risk factors for jumper’s knee between athletes
with jumper’s knee with non-symptomatic controls (Paper I, III, IV). 
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4. To compare sport history and training background as risk factors between athletes with 
jumper’s knee and non-symptomatic controls (Paper I, III, IV).
5. To characterize differences in the performance ability of the leg extensors in athletes with
jumper’s knee compared with a control group without knee symptoms (Paper III, IV). 
6. To characterize the ultrasound findings of the patellar tendon in athletes diagnosed with 
jumper’s knee compared with non-symptomatic athletes (Paper II). 
7. To study some potential pain mechanisms in patellar tendinopathy (Paper V). 
8. To study the histopathological findings in biopsies from patients with jumper’s knee 
compared with a control group without knee symptoms (Paper VI).
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Methods
Interview and clinical examination 
Study populations and interviews 
Paper I. This study was designed as a cross-sectional study among Norwegian athletes at the 
national elite level from different sports. Male athletes from eight different sports were examined;
athletics (high jump, 100 and 200 m sprint), basketball, ice hockey, orienteering, road cycling, 
soccer, team handball, volleyball and wrestling. In addition, female athletes from two of the same 
sports were examined; team handball and soccer. We wanted to examine approximately 50 
athletes in each sport, to provide a precision of 2-7% (proportion standard error) for the 
prevalence estimate in each group. In the team sports (basketball, ice hockey, team handball and 
soccer), elite division teams from the largest cities were invited to take part in the investigation,
and all invited teams agreed to take part. The teams were examined towards the end of their
competitive season. In the individual sports (athletics, orienteering, road cycling, wrestling), we 
asked athletes participating in the national championships, which were organized during the peak 
competition season, to take part in the study. All athletes who were present when we visited their 
team and all athletes we approached in the individual sports agreed to take part in the study.
Paper II and IV. This cohort study was carried out during an international volleyball tournament 
in Oslo, Norway in May 1994. The tournament was played 2 months after the end of the regular 
league season with teams competing in classes according to their level of play. The six Norwegian 
teams participating in the men's elite division in the tournament were invited to take part in the 
study. These were amateur teams that otherwise competed in the top division of the Norwegian 
Volleyball Federation (NVBF) leagues. The teams consisted of 53 players and of these, 47 (89%) 
consented to participate in an interview, a clinical examination, and an ultrasound examination of 
both knees. Each player went through an interview, and both knees were examined. They were 
asked about present and former knee injuries and complaints, specifically about symptoms of 
jumper's knee. Their symptoms were classified according to criteria by Roels et al. (1978), and 
Blazina et al. (1973). The 47 players who consented to take part were tested with a series of 
standardized jump and power tests described below. Their patellar tendons were also examined
ultrasonographically.
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Paper III. In this case-control study the patient and control groups were recruited from division I 
and II teams in the Norwegian Volleyball Federation (NVBF) leagues, which consisted of 16 
men's teams with a total of 164 licensed players. Of these, 141 players participated in two 
tournaments in September 1989 just prior to the start of the indoor season and these players 
were interviewed during the tournaments. The athletes in this study were asked about warmup
and stretching habits, type of floor in their normal training gym, type of shoe normally worn 
during volleyball training, as well as data on present and former knee injuries to ensure an 
identical matching as possible. All players with current knee complaints or a history of previous 
injury consented to go through a clinical interview and a standard knee examination. Players with 
current symptoms of jumper's knee were encouraged to report at the testing station for jump 
testing if they satisfied the following criteria: 1) Symptoms from the patellar tendon only; and 2) 
No history of intraarticular pathology (positive patella grinding test, positive meniscal tests, 
instability, locking, 'giving way' or joint effusion), rheumatic disease, previous fractures in the 
knee region, previous knee surgery or previous corticosteroid injections in or around the patellar 
tendon. A total of 12 players of those who reported for jump testing satisfied the criteria for 
inclusion in the patient group and successfully completed the standardized jump testing program. 
Also, a matched control group consisting of 12 players without knee pain consented to undergo 
an identical testing program. The control group consisted of players with no history of knee pain 
and a normal knee examination. The players in the control group were actively recruited to 
undergo the jump testing programs among team members of the injured players and the players
were individually matched with respect to age, function (middle blocker, outside hitter, setter), 
playing experience and training level.
Paper V and VI. The patient group was selected among athletes from different sports who had 
failed conservative treatment for patellar tendinopathy. The diagnosis was based on a typical
history and clinical findings combined with positive MRI findings compatible with tendinosis to 
ensure that the biopsies were taken from an area which was assumed to contain pathological
tissue. The duration of symptoms had to be more than 3 months. 
The control group was selected from patients with tibia fractures from low-energy trauma treated 
with marrow-nailing. These patients could not have current or previous knee complaints 
compatible with previous or current patellar tendinopathy. All individuals in both groups had to 
be more than 18 years old to ensure closed epiphyses. Exclusion criteria in both groups were 
previous surgical treatment in or around the same knee, previous corticosteroid injections in or 
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around the same knee, previous serious traumatic events affecting the same knee, all types of 
rheumatic disease and degenerative knee disorders.
Each patient went through a standardized interview, and the information requested from each 
athlete included age, height, weight and number of years participating in organized athletic 
training. Patients were asked to report the number of training hours per week during the 
competition season (sport specific training, weight training, jump training and other types of 
training). In order to assess the severity of the condition, the athletes diagnosed with current 
patellar tendinopathy also self-recorded their VISA score (Visentini et al. 1998).
Diagnostics
Standard form 
In all studies information requested from the athletes included age, height, weight, number of 
years participating in organized training, years of participation at the elite level, total number of 
training hours per week, number of hours sports specific training per week, weight training and 
jump training (plyometric training) done each week.
Each athlete went through a standard knee examination and clinical interview on present and 
former knee injuries and complaints. The following diagnostic criteria for jumper’s knee were 
used: History of pain localized to the lower patellar pole or insertion of the quadriceps tendon in 
connection with volleyball play and distinct palpation tenderness corresponding to the painful 
area (Blazina et al. 1973). Previous jumper’s knee was diagnosed based on history alone.
In order to assess the severity of the condition, the athletes diagnosed with current jumper’s knee 
in study III and IV were classified according to Roels et al. (1978) as modified by us (see Table 1, 
p. 18) 
In order to assess the severity of the condition in paper IV, V and VI, the athletes diagnosed with 
current patellar tendinopathy self-recorded their VISA score (Visentini et al. 1998). This is a 
validated pain and function score with a best score of 100 (no symptoms) and lowest score of 0 
(maximum symptoms), which has been developed specifically for this purpose and has been
shown to be a valid measure of symptoms (Robinson et al. 2001). 
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Biomechanical testing 
Paper III. In the first biomechanical study, the testing program was carried out using the 
Ergojump® equipment (KB Ergotest, Mikkeli, Finland), which consists of a contact mat 
connected to an electronic timer/computer (Bosco and Komi 1979, Bosco et al. 1983, Komi and 
Bosco 1978, Sale 1990). The equipment measures the flight time of each jump, and the jump
height (in cm) is calculated from this. In addition, power (W) is calculated from flight and contact 
times during rebound jumping (Bosco et al. 1983). The jumps performed were standing jump 
(SJ), counter-movement jump (CMJ), standing jump with a 20 kg load (SJ20 kg), standing jump 
with a load corresponding to one-half body weight (SJ1/2 bw), and a 15-s rebound jump test (RJ). 
As described by Komi and Bosco (1978), standing jumps were performed with the subjects 
starting from a stationary semi-squatting position with 90° knee flexion. No counter movement 
was allowed with any body segment, and hands are kept fixed on the hips. In the counter-
movement jumps the subjects started the movement from a stationary erect position with knees 
fully extended and they were then required to bend down to approximately 90° knee flexion 
before starting the upward motion of the jump. The 15-s rebound jump test consisted of 
continuous counter-movement jumps, where the subjects were encouraged to jump as high and 
as fast as possible for 15 s. Rebound jumping was also performed with hands fixed on the hips, 
and in each jump squatting down to approximately 90° knee flexion. In particular, care was taken 
to ensure that there was no counter-movement in the standing jumps and that the subjects 
landed with straight legs. The best out of three technically correct attempts was recorded and 
used for the statistical analysis, except for the 15-s rebound jump test, which was performed only 
once.
Paper IV. In the second biomechanical study, the players went through a standardized jump and 
power testing program. The testing program was performed using a contact mat connected to a 
computer (Intervall A/S, Oslo, Norway). The jumps performed were SJ, CMJ, DJ45 cm, SJ20 kg, SJ1/2
bw , SJ1/1 bw, and a RJ. DJ45 cm was a drop jump from a dropping height of 45 cm. Otherwise the 
performance of the different jumps was the same as described in Paper III. In addition, during 
the execution of the SJ1/2 bw and SJ1/1 bw tests, average velocity, force and power during the jump 
were measured using the Ergopower system (Ergotest Technology AS, Langesund, Norway). The 
equipment measures the displacement of gravitational loads, in this case barbells, as external 
resistance (Bosco et al. 1995). The vertical displacements of the loads are monitored with 
mechanical and sensor arrangements. When the subject moves the loads, the signal from the 
sensor interrupts the microprocessor every 3 mm of displacement. Thus, it is possible to calculate 
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velocity, acceleration, force, power, and work corresponding to the load displacements. The
system has been shown to be adequate in terms of its accuracy and reproducibility (Bosco et al. 
1995).
Figure 2. Illustration of the experimental setup for the jump tests. During all tests the players jumped on a contact mat
connected to a computer, making it possible to compute jumping height (Bosco et al. 1983). 
Ultrasound examination
Ultrasonography was performed using a 7.5 MHz real-time, linear array probe (Model Sonoline 
SI 400, Siemens, Germany). A stand-off gel mattress was used to enhance the image. The players 
were scanned in a supine position with the knee in about 30 degrees of flexion to ensure an 
extended tendon (Kälebo et al. 1991, Fornage 1987). All ultrasound examinations were 
performed by an experienced ultrasonographer who was blinded to the patients' history and the 
results of the clinical examination. The patellar tendon was examined for any of the following 
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changes: Hypo- or hyperechoic zones, signal changes in the anterior surface or the posterior 
margin, and bursa appearance. Care was taken to hold the probe perpendicular to the tendon
(Kälebo et al. 1991, Fornage 1987). The length of any hypoechoic zones was recorded. Prints of 
the images were also obtained for future reference. 
The lengths of the patella and patellar tendon were measured using longitudinal scans. Similar to 
the Insall-Salvati index (Insall and Salvati 1971), an index of patella length to patellar tendon 
length was calculated. Finally, the proximal and mid-part width and thickness of the tendon were 
measured using transverse scans (Fig. 3). Assuming an ellipsoid shape, the proximal and mid-part 
cross-sectional areas of the tendon were calculated as: ư x (W/2) x (T/2), where W is the width 
and T is the thickness of the tendon. 
Figure 3. Measurements of patellar length, and patellar tendon length, width and thickness of the patellar tendon as made on 
ultrasound scans.
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Immunehistochemistry
Surgical technique 
The surgical exposure was identical in the two groups, the patient group with patellar 
tendinopathy and the control group with tibia fracture, with a straight medial or lateral 
parapatellar incision, splitting of the paratenon and exposure of the patellar tendon. In both 
groups the biopsies were taken with the proximal limit at the bone-tendon junction. In the 
control group the biopsies were taken with a width of at least five mm and a length of at least 20 
mm from the middle portion of the tendon. In the patient group the biopsies were taken in the 
same manner, since the pathological tissue was confined to the middle and proximal part of the 
tendon. The biopsies were taken with full thickness of the tendon in the anterior-posterior 
direction.
Biopsy procedure 
The biopsy handling was identical in the two groups. Immediately after the surgical procedure, 
the biopsies were transferred to Zamboni solvent (Zamboni and De Martino 1967). The biopsies 
were stored in this solution for 4-24 hours, and then washed in 0.1 M phosphate-buffered NaCl 
(PBS), pH 7.2, with 15% sucrose (weight/volume) and 0.1% natriumazide. The biopsies were 
then stored in PBS at 4 °C for a minimum of 48 hours. They were stored in this way for later 
immune-histochemical analyses.
Nerve staining and analyses 
The samples were sectioned at 15 Pm on a Leitz cryostat and frozen sections were mounted
directly on Super-Frost/Plus glass slides and stained using the avidin-biotin or the haematoxylin-
eosin systems, for immunohistochemistry and light microscopy, respectively.
Immunohistochemistry
The slides were rinsed for 10 min in PBS. Incubation with 10% normal goat serum in PBS for 30 
min blocked nonspecific binding. Subsequently, the sections were incubated overnight in a humid 
atmosphere at +8Cq with primary antisera for protein gene product 9.5 (PGP, 1:10000,
Ultraclone, UK), a general nerve marker, substance P (SP, 1:10000, Peninsula Laboratories, USA) 
and tyrosine hydroxylase (TH, 1:5000, Peninsula Laboratories, USA), a rate-limiting enzyme 
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reflecting the occurrence of noradrenaline (NA). After incubation with the primary antisera, the 
sections were rinsed in PBS (3x5 min) and then incubated with biotinylated goat anti-rabbit 
antibodies (1:250, Vector Laboratories, CA, USA) for 40 min at room temperature. Finally, the 
sections were incubated for 40 min with Cy3-conjugated avidin (1:5000, Amersham International
plc, UK). Control staining was performed by omitting the primary antiserum. A Nikon 
epifluorescense microscope (Eclipse E800, Yokohama, Japan) was used for the analyses. The 
occurrence of PGP, SP and TH was subjectively assessed and pictures were taken for subsequent 
semi-quantitative analyses. 
Semi-quantitative analysis
After the subjective assessment, the following steps identified in an earlier study (Ackermann et 
al. 2002) were applied in order to optimize the semi-quantitative analysis: The patellar tendon
biopsies were sectioned longitudinally and the sections were numbered consecutively from the 
dorsal to the ventral aspect. Three sections from different levels, i.e. ventral, middle and dorsal 
parts of the tendon were chosen to represent the full thickness of the tendon. Staining was 
performed simultaneously for all sections to be compared. For microscopic analysis, a video 
camera system (DXM 1200, Nikon) was attached to the epifluorescence microscope and 
connected to a computer. From each section, one image from the microscopic field (20x 
objective) exhibiting the strongest immunofluorescence was stored in the computer. Thereafter, 
the images were analyzed using the software Easy Analysis (Technooptik, Sweden). The software 
denotes and considers all positively stained nerve fibers beyond a defined threshold of 
fluorescence intensity. The results were expressed as the fractional area occupied by positive 
fibers in relation to the total area. The fluorescent/total area was determined in three images in 
each biopsy of the patient and control groups, respectively. In the microscopic analysis, the mean 
interobserver coefficient of variation was 9.8 % and the intraobserver variation was 9.6%. For 
statistical analysis, the mean fluorescent/total area was calculated for each of the ten biopsies
from both the patient and the control group. 
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Apoptosis assessment
Light microscopic appearance 
5 μm sections were routinely stained for H&E (general morphology) and Alcian Blue (sulphated 
glycosaminoglycans) and viewed at 100 to 630x magnification on a Zeiss Axioplan upright
microscope.
Detection of apoptosis and assessment of caspase activation
Apoptosis was assessed using a monoclonal antibody against single-stranded DNA breaks (F7-26; 
Chemicon, Temecula, U.S.A.), as well as with a polyclonal antibody against the active (cleaved)
form of caspase-3 (Asp 175; Cell Signaling), and propidium iodide staining (Sigma-Aldritch) for 
nuclear morphology. Of these methods, the cleaved caspase-3 antibody yielded the most specific 
and reproducible labeling of apoptotic cells in tonsil tissue (serving as a positive control), and was 
thus used for systematic quantification. The sections were cleared, quenched in 3% hydrogen 
peroxide, incubated in protein-free block for 15 min, then left overnight with the antibody
diluted 1:50 in 0.1% bovine serum albumin in tris buffered saline (TBS). Slides were then 
sequentially exposed in a dark, moist chamber to horse radish peroxidase-conjugated goat-anti-
rabbit (1:100, 30 min), fluorescyl-tyramide amplification reagent (DAKO Diagnostics, Glostrup, 
Denmark), anti-fluroescein-horse radish peroxidase, and finally 3,3'-diamino-benzidine (Vector 
Laboratories, Burlingame, U.S.A.) for 5’, with 3x5’ washes in TBS between each step. Bouin’s
fixed tonsil with or without the primary antibody was used as positive or negative control,
respectively.
Image analysis
The identity of slides was masked with black tape. Using a 40x objective lens, the tissue section
was illuminated with halogen or fluorescent light (488 nm wavelength) and respective areas of 
positive F7-26 or propidium iodide staining were captured at 1392 x 1045 pixels with a digital 
camera (Retiga Exi 1394, Qimaging Corp, Burnaby, Canada). For quantitation of apoptosis, 
fifteen random areas (0.30 mm2 each) from the proximal region were digitized. Cells were 
considered positive only if the labeling was dense and suggestive of apoptotic morphology. A 
standard exposure time (50ms) was used through, and the contrast was not digitally adjusted. 
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Ethics
Study II, III, IV, V and VI were approved by the Regional Ethical Committee for Medical 
Research. In all six studies participation was voluntary and consent was obtained.
Statistics
In paper IV, in order to evaluate the performance ability of the leg extensors for each player a 
composite jump index was calculated by rating each player's result on a scale from 0 to 100 on 
each of the following jump tests: SJ, CMJ, CMJ-SJ, DJ, RJ, SJ20 kg, SJ1/2 bw (power) and SJ1/1 bw
(power), where 0 represents the lowest test score among all the players tested and 100 the best 
score. The overall score was computed as the average of the results from each of these eight 
scores. Descriptive data are given as means ± SD and/or range unless otherwise noted. 
Comparisons of continuous data between groups were done using analysis of variance or 
unpaired t-tests, as noted in the results. Prevalence was compared between groups using Pearson 
chi-square tests. In paper IV proportions are reported with the corresponding SE, where 
relevant. In paper IV multiple logistic regression was used to test the effect of potential risk 
factors for jumper’s knee (age, height, weight, experience at elite level, volume of sports specific 
training, weight training and jump training), adjusting for differences between sports. An alpha 
level of 0.05 was considered significant.
In Paper VI, for quantitation of apoptosis, the following variables were compared using caspase-
3-labeled tissue sections; total number of positive cells in all areas, number of positive fields, 
average number of positive cells per field, and Apoptotic Index (% positive cells in all fields).
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Results and discussion 
Prevalence data 
Results
Paper I. The overall prevalence of current jumper’s knee was 14.2±1.4% (87 of 613 athletes). Of 
the 87 athletes with current symptoms, 37 had bilateral symptoms, while 30 athletes had
symptoms from the right side only and 15 players had symptoms from the left side only. This 
means that the prevalence of current jumper’s knee affecting the right knee was 10.9% (67
players) and of the left knee 9.3% (57 players). In addition, 51 athletes (8.3%) reported previous 
symptoms of jumper’s knee affecting one or both legs, resulting in a prevalence of current or 
previous symptoms of  22.5% (138 of 613 athletes). Only one athlete diagnosed with current 
jumper’s knee localized the pain to the quadriceps tendon insertion at the upper patellar pole, the 
rest localized the pain to the patellar tendon. 
As shown in Fig. 4, there were significant differences in the prevalence of current jumper’s knee 
(Ʒ2 test, p<0.001), as well as in the prevalence of previous symptoms (Ʒ2 test, p<0.001). The
prevalence of current symptoms was highest in volleyball with 44.6±6.6% and basketball with 
31.9±6.8% while there were no cases in cycling or orienteering.
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Figure 4. Prevalence (%) of current (white bars) and previous (hatched bars) symptoms of jumper’s knee. The results for 
female athletes (F) are shown in the two upper bars, the rest of the results are for male athletes. Error bars denote SE.
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The mean symptom duration among athletes with current jumper’s knee was 32±25 months 
(range: 1-144 months, n=87). There was a significant difference in symptom duration between 
the different sports (ANOVA, p=0.04).
The mean VISA score reported across sports and genders was 64±19. As seen in Fig. 5, the 
VISA score reported by players with current symptoms of jumper’s knee was significantly 
different between sports (ANOVA, p=0.003). The lowest VISA score was reported by male team
handball players and the highest by ice hockey players.
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Figure 5. VISA scores for players with current symptoms of jumper’s knee in the various sports groups. For players with 
bilateral symptoms, the lowest value (worst knee) has been used. The top two hatched bars show the results for female athletes
(F) from soccer and team handball, the open bars show the results for male athletes. No results are given for orienteering and 
cycling, since there were no athletes with current symptoms in these groups. The bars and error bars denote the mean and SD.
In addition, the filled circles show the lowest and highest value in each group.
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Paper III. In Paper III we examined 16 men's Division I and II teams with a total of 164 licensed 
players. Of these, 141 players participated in two tournaments in September 1989 just prior to the 
start of the indoor season and these players were interviewed during the tournaments. 55 players 
(38%) were diagnosed with current jumper’s knee. 
Paper IV. Of the 47 players participating in the study, 24 players (51.0%) were clinically diagnosed 
with current jumper’s knee affecting at least one side. Twenty players (42.6%) had never 
experienced problems from any knee, whereas 3 players reported having had previous knee 
problems identified as jumper’s knee (6.4%). The severity of symptoms among those with current 
jumper’s knee (n=33 knees) was classified as grade I in 6 knees, grade II in 18 knees and grade 
IIIa in 9 knees. The onset of symptoms was gradual in 31 knees (94%) and acute in 2 knees, and 
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the duration of symptoms reported by the players with current complaints of jumper’s knee was 
3.5±2.4 (0.1-10) yrs. The age at symptom onset was 18.8±2.8 yrs (13.5-25.9).
Discussion
The main finding of Paper I was that the overall prevalence of jumper’s knee was 14% across the 
sports included. In addition, 8% of the athletes reported previous symptoms, indicating that 
every fifth elite athlete is affected by jumper’s knee during their athletic career. The prevalence 
varied between sports—from no cases in cycling and orienteering to 45% with current symptoms 
in male volleyball. In Paper III the prevalence of current jumper’s knee was 38% and in Paper IV 
51%. These prevalence figures probably represent minimum estimates since the athletes with the 
most serious problems, those who could not participate in training or competition, were not 
included in the studies. We do not know the number of athletes who were too disabled to be 
included. This may be a significant source of error, particularly in the individual sports, where it is 
more likely that an athlete would withdraw or not even enter the national championships if he 
thought that he could not perform fully. Also, an unknown number of athletes may have retired 
early because of jumper’s knee, and some may have settled for a career on a lower level of 
performance because they could not tolerate the heavy training and competition load at the elite 
level. Thus, the elite samples we were able to study represent the survivors, and the true career
prevalence is higher than that reported here as an overall result across the sports included. 
It should also be noted that the mean duration of the symptoms was 32 months with a mean 
VISA score of 64. The information on the duration of the symptoms is based on memory, which 
means that the precision of this information is uncertain. Nevertheless, it seems clear that even 
with this limitation, there is no doubt that the majority of patients have played with symptoms for 
several years. This means that this condition can severely interfere with athletic performance, and 
even threaten an athletic career.
Another methodological limitation which must considered when interpreting the results is that 
the results are based on clinical examination alone, except in study II where we did an ultrasound 
examination. For practical reasons, we were not able to do MR or ultrasound imaging in the 
other studies to confirm the presence of structural tendon changes. This means that to be
recorded as having current symptoms of jumper’s knee, the athlete had to report a painful tendon 
during athletic activity with corresponding palpation tenderness. It may be argued that this
definition is unspecific, since we do not know for certain that the tendon was the source of the 
pain in all cases. For instance, we could not rule out cases with referred pain, principally from the 
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distal aspects of the articular surface of the patella. In fact, a number of studies have shown that 
the correlation between clinical findings and ultrasound (Myllymäki et al. 1990, Cook et al. 2000a, 
Khan et al. 1997, Khan et al. 1999) or MR (Davies et al. 1991, Bodne et al. 1988, Khan et al. 
1996) examinations is low, and even that symptoms and tendon changes come and go 
independently (Cook et al. 2000a, Cook et al. 2001). A significant number of athletes have or 
develop visible tendon changes without symptoms of jumper’s knee and some have significant 
pain without detectable tendon changes (Cook et al. 2001). Thus, we would argue that the current 
clinical definition provides the most valid estimate for the prevalence of jumper’s knee, since it 
will detect all players with tendon symptoms during athletic performance.
To our knowledge, there are no previous reports on the prevalence of jumper’s knee across 
different sports, although a number of case series presenting the outcome after surgical treatment 
indicate that the majority of patients are from sports with high demands on speed and power 
(Karlsson et al. 1991, Raatikainen et al. 1994, Martens et al. 1982) 
As expected, in the present study the prevalence was high in volleyball and basketball (55% 
reporting current or previous jumper’s knee), sports characterized by high demands on speed and 
power. The maximal muscle force that can be generated eccentrically is 1.5-2.0 times higher than 
the maximal isometric force, and several-fold higher than maximal concentric force, especially at 
high speeds (Herzog 2000). Also, the ground reaction force is different between different tasks, 
ranging from 2.8 times body weight during distance running to 6 bw during jumping in volleyball 
and 10 bw in a long jump take off (McNitt-Gray 2000).The highest ground reaction forces are 
seen with ballistic drop jumps, and the resulting forces through the extensor tendons are 
proportional to the ground reaction force. Therefore, it is reasonable to suggest a connection
between the loading pattern of the knee extensors and the prevalence of jumper’s knee. This 
seems to match the prevalence distribution seen in the present and previous studies, with the 
highest in basketball and volleyball (high jump volume and eccentric load), then athletics 
(sprinters and jumpers, high load, but less volume), followed by team handball, soccer and ice 
hockey (less jumping, some sprinting) and low prevalence among orienteerers (high volumes of 
running, but no sprinting) and road cycling (high volumes of concentric work, no ballistic 
loading).
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Gender
Results
Paper I. The prevalence of current jumper’s knee was lower among women with 5.6±2.2% (6 of 
107 team handball and soccer players) compared with a combined prevalence of 13.5±3.0% (18 
of 133) in the corresponding male sports (Ʒ2 test, p=0.042). However, there was no difference (t-
test, p=0.48) in the duration of symptoms between female (22±12, n=6) and male athletes
(28±21, n=55). Also, there was no gender difference in VISA score. The VISA score in female 
team handball and soccer was 59±15, compared with 58±23 in the same male sports (ANOVA,
p=0.9).
The number of years of participation in organized training was 15.2±5.1, with 6.1±4.2 years at 
the elite level. The number of hours with sport-specific training was 11.8±3.9. There was no 
significant gender difference in these variables between athletes with current jumper’s knee and 
those without.
Discussion
Gender as a risk factor for jumper’s knee had not been studied before in contrast to acute knee 
injuries, particularly ACL tears (Myklebust et al. 1998, Arendt and Dick 1995). The prevalence of 
current symptom was 5.6% among female team handball and soccer players compared with 
13.5% in the corresponding male sports. The question is what the cause of the apparent gender 
difference is. We chose team handball and soccer to examine the gender difference, since these 
are sports which in Norway are played at an equally high performance level by men and women, 
where we therefore thought player experience and training volumes would be similar. Also, we 
expected a relatively high prevalence of jumper’s knee in these sports. As seen from Table 4 in 
Paper I, the training volumes (15-17 h/week total training time) and background (15-18 years of 
organized training, 5-7 years at the elite level) were similar between men and women. The 
difference in prevalence may be attributed to a number of other factors. It is well documented
that the jumping ability and force-generating capacity is lower among women than men (McNitt-
Gray 2000). So, even if the number of sprints and jumps may be similar between men and
women playing the same sports, the lower prevalence may simply reflect that the forces that are 
transmitted through the quadriceps and patellar tendons are lower among women. 
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Antropometrical data 
Results
In Paper I athletes with current jumper’s knee weighed more (83.6 kg±11.6 vs. 77.3 kg±11.9, 
p<0.001) and were taller (186±9.5 cm vs. 181±9.2 cm, p<0.001). 
In male soccer the jumper’s knee group was significant taller than the others (186 ±4.3 cm vs.183 
±5.5 cm, p=0.05). Otherwise, there were no other significant differences between those with 
jumper’s knee compared with those without within each sport with regard to age, height and 
weight. In a logistic regression model which included gender, sport, age, height, weight, training 
background, and the volume of the different types of training, only weight training and jump 
training were significant factors. 
In Paper III there was no difference between the groups with regard to age, height and weight. 
In Paper IV players with jumper’s knee had a significantly higher body weight than the controls,
but there was no difference in height and age.
Discussion
Age was not a significant risk factor for jumper’s knee in any of the present studies. Among
volleyball players there was no significant difference in height between players with jumper’s knee 
compared with controls. In the overall material in Paper I (prevalence study), the athletes with 
jumper’s knee were significantly taller, but within each specific sport there was only significant 
difference in height among male soccer player. In a logistic regression model which included 
gender, sport, age, height, weight, training background, and the volume of the different types of 
training, only weight training and jump training were significant factors. As a conclusion, height is 
not a significantly associated risk factor for jumper’s knee. In Paper I and IV athletes with
jumper’s knee were significantly heavier than those without jumper’s knee. We did not examine 
body composition, but it seems unlikely that the body weight difference observed was due to 
differences in body fat in such a well-trained population of players. The players with jumper’s 
knee reportedly trained significantly more with weights than the others in study II and IV. This 
weight training by itself means a higher total loading of the extensor apparatus, and the 
anticipated effect of this training is also to increase muscle mass and jumping ability.
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Sports history and training background
Results
Paper I. The number of years of participation in organized training was 15.2±5.1, with 6.1±4.2
years at the elite level. The number of hours with sport-specific training was 11.8±3.9. There was 
no significant difference in these variables between athletes with current jumper’s knee and those 
without. However, athletes with current jumper’s knee did significantly more weight training 
(3.5±2.4 h/week vs. 2.5±2.1, p<0.001) and jump training (1.1±1.8 h/week vs. 0.5±1.0, p<0.001).
The comparison between athletes with current jumper’s knee and those without within each
specific sport showed that in basketball, the athletes with jumper’s knee did significantly more 
sport-specific training than those without jumper’s knee (14.7±2.7  h/week vs. 12.3 ±2.5 
h/week, p=0.005). In male handball the athletes with jumper’s knee did significantly more 
plyometric training compared with those without jumper’s knee (0.7±1.0 h/week vs. 0.2±0.3 
h/week, p=0.01). In a logistic regression model which included gender, sport, age, height, weight, 
training background, and the volume of the different types of training, only weight training and 
jump training were significant factors.
Paper III. In this study the players with jumper’s knee did a significantly higher number of weekly 
training sessions compared with the athletes without jumper’s knee. There was no difference 
between the groups with regard to number og seasons played, weight training, jump training, 
warm-up time or stretching time.
Paper IV. The characteristics of the players and their training background are shown in Table 2. 
The prevalence of current jumper’s knee was significantly higher among outside hitters (68%) 
and middle blockers (64%) compared with utility players (28%) or setters (18%). 
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Table 2. Characteristics of players with current symptoms of jumper’s knee (n=24), and without history of jumper’s knee
(n=20). Values are means ± SD. *Significantly different from players without history of jumper’s knee (unpaired t-tests). 
Current
jumper's knee 
No history of
jumper's knee 
Significance
level (p) 
Organized volleyball training (yrs) 8.0±2.8 7.5±3.6 0.55
Training at senior level (yrs) 6.8±2.5 5.7±3.6 0.28
Training at elite level (yrs) 2.5±2.6 2.2±3.2 0.70
Volleyball training (h/wk) 7.7±2.1 7.4±1.6 0.53
Weight training (h/wk) 4.5±2.8* 2.3±2.3 0.009
Jump training (h/wk) 0.4±0.9 0.6±1.1 0.53
Sum training (h/wk) 12.6±4.2 10.3±3.9 0.06
Stretching during warm-up (min) 3.4±3.0 3.1±2.7 0.71
Stretching after training (min) 6.2±5.8 7.1±3.9 0.55
Discussion
Epidemiological studies on extrinsic factors have shown that the hardness of the playing surface 
and an increased frequency of training sessions correlate positively with the prevalence of 
jumper’s knee (Ferretti et al. 1984, Ferretti 1986). This is supported by the results in Paper I, 
which shows a small, but significant difference in training volume between players with and
without symptoms. In Paper II we found no difference between the groups in the total amount
of specific volleyball training, since all the players were selected from a well-trained group with a 
similar training history. In Paper I, athletes with jumper’s knee did significantly more jump
training. In the same study the sport with the highest prevalence of jumper’s knee was basketball
(55% reporting current or previous jumper’s knee), a sport characterized by high demands on 
speed and power. In this sport, athletes with current jumper’s knee did significantly more sport-
specific training than those without jumper’s knee. In other words, there is substantial evidence
to suggest a link between the total load on the tendon and the prevalence of jumper’s knee. 
Volleyball involves approximately 60 maximal jumps per hour of play, and previous studies have 
shown that the prevalence of jumper's knee increases with increased frequency of training 
(Ferretti et al. 1984, Neri 1991). The tactics of the game require middle blockers jump more than 
others, and it has been shown that they have a higher prevalence of jumper's knee (Neri 1991). 
We did find that the prevalence of jumper’s knee was significantly higher among outside hitters 
and middle blockers compared to utility players and setters. This is not surprising, since outside 
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hitters and middle blockers perform a much higher number of maximal jumps than setters as a 
result of their function on the team. In line with this, it has recently been shown that the 
prevalence of jumper’s knee among elite beach volleyball players is only 9%, considerably lower 
than in indoor volleyball players (Bahr and Reeser 2003). The explanation for this difference in 
prevalence is probably that jumping and landing in soft sand is less demanding on the tendon 
than is jumping on indoor playing surfaces. Thus, there is reason to suggest that the prevalence 
of jumper's knee in volleyball players is closely related to the volume of jumping and playing 
surface hardness.
The players with jumper’s knee reportedly trained more with weights than the others (Paper I and 
IV). In Paper I, a logistic regression model which included gender, sport, age, height, weight, 
training background, and the volume of the different types of training, only weight training and 
jump training were significant factors. This weight training by itself means a higher total loading 
of the extensor apparatus, and the anticipated effect of this training is also to increase muscle
mass and jumping ability. This is supported by the fact that the players with jumper’s knee had a 
higher body weight than those without jumper’s knee. 
However, in the present studies we do not have detailed information on the training history of 
the players at the time they were first injured. At that time there may have been differences in e.g. 
training volume or intensity that we were unable to detect in a cross-sectional study, and 
longitudinal studies are necessary to examine in detail how training programs may lead to tendon 
overload.
Biomechanical data 
Results
Paper III. The players from the patient and control groups came from the same teams, used the 
same type of shoe, and trained and played on the same type of gym floor. The characteristics of 
the patient group and the matched control group who underwent the jump testing program are 
shown in Table 3. 
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Table 3. Characteristics of patient group (n=12) and control group (n=12). Values are means ± SD. *Significant 
difference between groups.
Patient group Control group
Age (yrs) 23.7 ± 3.0 24.8 ± 4.6
Height (cm) 189.3 ± 7.0 187.9 ± 4.9 
Weight (kg) *84.1 ± 5.6 79.2 ± 3.7
No. of seasons played 7.2 ± 2.2 8.5 ± 2.8 
No. of training sessions per 
week 4.6 ± 1.2 4.3 ± 1.1 
Weight training (h/wk) 1.0 ± 1.0 1.0 ± 0.6 
Jump training (h/wk) 0.3 ± 0.7 0.5 ± 0.5 
Warm-up time (min) 19 ± 7 20 ± 3 
Stretching time (min) 6 ± 4 5 ± 3 
In the jump tests the patient group performed better than the control group in the counter-
movement jump, the standing jump with a 20 kg load, and the 15-second rebound jump test. 
Also, the work done in counter-movement and standing jump was greater in the patient group, as 
was the difference between jump height in counter-movement and standing jumps.
Paper IV. The jumper’s knee group scored significantly higher than the control group on the 
composite jump score (50.3 vs. 39.2, p=0.02), and significant differences were also observed for 
work done in the drop jump, and average force and power in the standing jumps with half and 
full body weight loads. 
Thirty-seven players (79%) reported using a right-left step-close takeoff technique in the spike 
jump, whereas 10 players (21%) used a left-right takeoff. Only one player reported preferring the 
right leg when landing after the attack, whereas 31 players (66%) reported a balanced landing
technique, and 15 players (32%) reported favoring their left leg when landing. The takeoff and 
landing techniques among the players with current jumper's knee are shown in Table 4. 
40
Results and discussion
Table 4. Takeoff and landing technique in spike jump among players with current jumper’s knee on the right and left side. 
Right knee 
(n=22)
Left knee 
(n=11)
Right-left takeoff 20 11
Left-right takeoff 2 0
Right-left landing 0 0
Left-right landing 6 4
Simultaneous landing 16 7
Discussion
The main finding of these studies was that the groups of players with jumper’s knee performed 
better in standardized series of jump and power tests compared with the control groups.
Dynamic characteristics such as jumping capacity and loading of the extensor mechanism are by 
definition possible intrinsic predisposing factors for jumper’s knee. However, data on intrinsic 
disposing factors for jumper’s knee is limited and it is not known why some players have 
problems, whereas others do well despite almost identical external predisposing factors, such as 
high training and jumping volumes. There is no convincing evidence in support of suggestions 
that injury may be associated with malalignment of the extensor mechanism of the knee, patella 
alta, abnormal patella laxity or other structural abnormalities (Ferretti et al. 1984, Ferretti 1986, 
Kujala et al. 1986, Kujala et al. 1989, Kujala et al. 1987, Torstensen et al. 1994). However, the 
problem may be related to the performance characteristics of the leg extensors. Players who jump 
well load their tendons more than others and this may lead to a greater risk of injury. Our data 
seem to indicate that this is the case, because the patient group in both studies performed better 
compared with the control group.
In Paper III it is interesting to note that the test results did not differ between the groups for all 
modes of jumping. The standing jump is designed as a "pure" concentric movement, and the 
results for unloaded jumping did not differ between the groups. However, for the counter-
movement jump, which consists of a ballistic movement of a rapid eccentric muscle action 
immediately followed by a maximal concentric contraction, there was a significant difference 
between the groups. We also observed a significant difference in the 15-second rebound jump 
test, which consists of a series of ballistic jumping movements. Consequently, it may be suggested 
that the main difference between the groups could be the way in which they were able to utilize 
the eccentric pre-stretch component of the ballistic motion to increase their jumping height. 
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However, we could not reproduce these results in Paper IV. Paper III included a smaller number 
of players, and in a case-control study it is possible that a selection bias may have occurred. 
However, the performance of the players with jumper’s knee in Paper III in the counter-
movement jump test and the rebound jump test was significantly better than the results of the 
players in Paper IV. This suggests that the injured players in the first study had a highly 
developed leg extensor apparatus, which may implicate a stronger predisposition towards
jumper’s knee. 
The right knee was affected twice as often as the left knee (Paper IV). The majority of the players 
used a right-left step-close takeoff technique, and none of the players reportedly preferred the 
right leg when landing after the attack. In fact, 20 of the 22 players with current jumper's knee on 
the right side used a right-left takeoff technique. This suggests that a relationship may exist 
between the takeoff technique and jumper’s knee, and that the forces sustained during takeoff 
may be of considerable importance. In order for a right-handed player to obtain proper 
alignment of the upper body for an effective spike, the preferred technique involves placing the 
right foot first and about 45º externally rotated (Selinger and Ackermann-Blount 1986). When
using this takeoff technique, the deceleration work is mostly done with the right leg, subjecting it 
to higher eccentric loading than the left leg. Also, when these high loads are imposed, the right 
leg may be in a state of functional malalignment. The preferred takeoff technique results in a 
valgus position of the right leg, a greater flexion angle of the knee, as well as external rotation of 
the tibia relative to the femur. It is possible that these factors result in a more unfavourable 
loading pattern of the right knee with respect to development of jumper’s knee. Motion analysis 
and direct force measurements are necessary to study this phenomenon in more detail. Based on 
the present studies there is reason to suggest an overall better jumping capacity, especially in 
jumps with an eccentric component, as important intrinsic predisposing factors for jumper’s 
knee.
For the injured athletes to have been able to jump higher than the control subjects, a larger 
vertical impulse must have been produced. Force was not measured directly in Paper III, but it is 
likely that the force transfers through the patellar tendon were larger as well. From previous 
studies of volleyball players, it is known that good jumpers are characterized by a shorter contact 
time and higher peak force during take-off (Selinger and Ackermann-Blount 1986). Thus, the 
difference in peak force is likely to be larger than the difference in the jump result alone would 
seem to indicate. Since more than 50% of the work done in jumping is produced by the knee 
extensors (Luhtanen and Komi 1978), it seems reasonable to conclude that the differences 
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observed in jumping height reflects a true increase in the force transfer through the patellar
tendon.
The jumping ability of the players, 40-45 cm in a counter-movement jump, may not seem 
impressive. However, the jumping mode tested differs from the techniques used when playing
volleyball. In a spike jump players usually employ an approach run of two steps, a step-close take-
off technique and a full arm swing, thereby adding another 55-65% to their counter-movement 
result (Bahr et al. 1992). There is a close correlation between the results of a counter-movement 
jump and a spike jump (r=0.96) (Bahr et al. 1992), and based on this relationship the spike jump 
of this group of injured players may be estimated to range from 55 to 92 cm. The forces involved 
during take-off and landing are also larger than during the standard test situation used in the 
present study (Bahr et al. 1992). 
In Paper IV the composite jump index was designed as an overall indicator of a player's ability to 
load the extensor apparatus during conditions ranging from slow-speed concentric (standing
jump with added load) to high-speed ballistic (rebound jumps). The dynamic testing program was 
selected to resemble the various loading conditions imposed on the leg extensors during different 
jumping and cutting movements used in the game of volleyball. The significant difference 
observed between the groups in the composite jump index may be taken as an indication that the
leg extensor apparatus in the group with jumper’s knee may be subjected to higher loads during 
volleyball play, as well. There were significant differences between the players with current 
jumper’s knee and those without both in average force and average power in standing jumps with 
added loads corresponding to one-half and whole body weight. Consequently, the forces acting 
on the tendon or the rate of force development during jumping may surpass the adaptive abilities 
of the tendon.
The study designs have some limitations which must be borne in mind when interpreting the 
results. It is possible that the selection of athletes to the patient group was biased, since 
diagnostic criteria were based on a typical history and clinical findings alone. However, we 
included only athletes with a typical history of patellar tendon pain in the patient group, and care 
was taken to exclude athletes with evidence of additional or other pathology. In Paper III the 
matching of the control players from the same teams based on age, function, playing experience 
and training level was felt to be the best way to minimize the risk of a selection bias. While the 
study format allowed us to match the patient and control groups carefully with respect to 
diagnosis and factors believed to be of importance in the development of jumper's knee, it also 
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resulted in a small sample size, and the results therefore needed to be validated in a larger 
population of athletes as in Paper IV. 
The jump testing protocol is a standard program which has been shown to be highly reproducible 
(Sale 1990). The tests are functional, designed to give an estimate of performance at different 
speeds and loads, much in the same way that different demands are placed on the leg extensors 
for given tasks during the actual game of volleyball. The tests were familiar to the examiners as 
well as many of the teams, who use the same tests on a regular basis to check the efficacy of their 
training programs. Pain inhibition during jump testing among the players in the patient group is 
possible. The players did not express any problems and even if this occurred, it would appear not 
to invalidate the results, since the patient group still performed better than the control group. 
An interesting observation in this connection is that athletes with longstanding complaints from 
what is supposed to be an overload condition perform better in dynamic tests with high 
resemblance to the movements and loading mechanisms of the extensor apparatus which is 
supposed to be the reason to the injury compared with asymptomatic athletes. However, whether 
the athletes with jumper’s knee actually have reduced performance level compared with their 
preinjury level or not can only be answered through longitudinal studies. Since the athletes with 
jumper’s knee perform better compared with controls in dynamic testing procedures even with 
serious symptoms for many years we can not explain their reduced performance level by reduced
performance of their extensor mechanism. The problems the athletes with   reports are correlated 
to their experiences of pain. This means that there is reason to suggest a connection between a 
high jumping capacity and high training volumes and the pain mechanisms within the tendon. It 
is also reason to suggest a correlation between an overload condition giving specific 
histopathological changes that can explain the pain mechanisms since the histopathological 
findings are consistent and uniforme (Roels et al. 1978, Karlsson et al. 1991, Colosimo and 
Bassett 1990, Bassett et al. 1980, Khan et al. 1998). 
Ultrasound data
Results
Paper II. Palpation tenderness was found in a number of players who did not complain of 
symptoms of jumper's knee, and the predictive value of pain on isometric contraction was low 
(Table 5). Previous Osgood-Schlatter's disease was reported in 2 cases among those with current 
jumper's knee (34 knees), and in 8 of 60 knees without current symptoms (n.s.)
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Table 5. Clinical findings in 34 knees with current jumper's knee and 51 knees without symptoms. Knees with previous
symptoms (n=9) only were excluded from the analysis.
Test Test result Current symptoms(n=34)
No symptoms
(n=51)
Negative - 39
Slight 9 6
Moderate 12 6Palpation tenderness 
Strong 13 -
No 24 48Pain on isometric
contraction (0q) Yes 10 3
No 29 51Pain on isometric
contraction (30q) Yes 5 -
No 31 51Pain on isometric
contraction (90q) Yes 3 -
Negative 27 43Chondromalacia tests Positive 7 8
Tendon changes observed by ultrasonography 
Table 6. Dimensions of the patellar tendon and patella in athletes with (n=30 knees) or without (n=51) current symptoms
of jumper's knee. Knees with previous symptoms or symptoms from the quadriceps tendon only were excluded from the
analysis (n=13). Values are means ± SD.
No symptom Current symptoms Significance level (P)* 
Tendon length (mm) 52±5 53±7 0.29
Patella length (mm) 38±3 39±3 0.79
Insall-Salvati index 0.75±0.10 0.73±0.08 0.46
Proximal thickness
(mm) 3.8±1.1 6.2±2.2 <0.001
Proximal width (mm) 33±3 33±4 0.65
Proximal area (mm) 99±29 161±60 <0.001
Midpoint thickness
(mm) 3.9±0.7 4.1±0.5 0.21
Midpoint width (mm) 36±3 37±6 0.003
Midpoint area (mm2) 108±20 120±19 0.08
*Unpaired t-test.
The degree of clinical symptoms could not be reliably predicted from the changes observed in 
paratenon appearance or by the presence of hypoechoic changes. The length of the hypoechoic 
zone was 11.5±4.2 mm among those without symptoms, and 10.0±0.0 mm, 14.4±2.8 mm and 
20.1±8.4 mm among those with grade I, II and IIIa symptoms, respectively (n.s., ANOVA). 
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No increase was observed in proximal tendon thickness or length of any echoic changes 
observed in relation to the duration of current symptoms of jumper's knee. 
Discussion
The main finding of this study was that the prevalence of jumper's knee and ultrasound changes 
in the patellar tendon was high, approximately 50%, but that the correlation between symptoms 
and ultrasound changes was low. In the present study, 7 of the 30 knees with a clinical diagnosis 
of jumper's knee in the patellar tendon had normal ultrasound findings. On the other hand, we 
found ultrasound changes believed to be associated with jumper's knee (tendon thickening, echo 
signal changes, irregular paratenon appearance) in 12 of 51 knees without current or previous 
symptoms.
The findings in the present study have later been confirmed by others. In a cross-sectional cohort 
study by Cook et al. (1998), they assessed the sonographic patellar tendon appearance in 320 
athletes from different sports (basketball, cricket, netball and Australian rules football) without 
any current or previous complaints  compatible with jumper’s knee compared with 27 nonathletic 
individuals as controls. In the asymptomatic group of athletes they found hypoechoic changes in 
the tendon in 22% and in 4% in the control group, in 30% of male and 14% of female athletes 
without symptoms, and in 32% of asymptomatic basketball players compared with 9% in the 
other sports (all p<0.05). In another study by Cook et al. (2000b) they studied the patellar 
tendons in 134 elite 14- to 18-year old female (n=64 and male (n=70) basketball players and 29 
control swimmers (17 female and 12 male) clinically and ultrasonographically. Of tendons 
categorised clinically as “never patellar tendinopathy”, 22% had an ultrasonographic hypoechoic 
region.
To evaluate the ability of ultrasonography to predict eventual symptoms Khan et al. (1997)
compared patellar tendon sonographic findings at baseline and at follow-up in female basketball
players with and without symptoms of jumper’s knee. They concluded that patellar tendon
sonographic hypoechoic areas can resolve, remain unchanged or expand in active sports-women 
without predicting symptoms of jumper’s knee. Cook et al. (2000a) did a longitudinal study on 52 
elite junior basketball players with an ultrasonographic evaluation at baseline and after 16 months. 
All tendons were asymptomatic at baseline and 10 had hypoechoic changes at baseline and 42 
were ultrasonographically normal at baseline. The relative risk for developing symptoms of 
jumper’s knee was 4.2 greater in case tendons than in control tendons. Half of the abnormal 
tendons in women became ultrasonographically normal in the study period. Based on their data 
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they suggest that the presence of an ultrasonographic hypoechoic area is associated with a great 
risk of developing symptoms of jumper’s knee. They concluded that neither qualitative nor 
quantitative analysis of baseline ultrasonographic images made it possible to predict which 
tendons would develop symptoms or resolve ultrasonographically. In another study by Cook et 
al. (2001), they used a longitudinal study design to examine whether or not the presence of a 
hypoechoic lesion in an asymptomatic patellar tendon conferred a risk for developing jumper’s
knee compared with a tendon that was ultrasonographically normal. They followed 46 patellar 
tendons over 47 ± 12 months. Eighteen tendons had hypoechoic changes at baseline and 28 were 
ultrasonographically normal. Five tendons resolved ultrasonographically in the study period.
Seven normal tendons at baseline developed hypoechoic changes but only two became 
symptomatic. Analysis of ultrasonography at baseline and clinical outcome showed that there was 
no association between baseline ultrasound changes and symptoms at followup. There was no 
statistical significant relationship between ultrasonographic patellar tendon abnormalities and 
clinical outcome in elite male athletes. As a conclusion from the available studies there is ample 
evidence to state that the relationship between symptoms and clinical findings of jumper's knee 
and the ultrasound changes is weak.
Several authors have described the histopathological changes in the patellar tendon obtained 
from surgical specimens in patients with disabling jumper's knee, and their observations usually 
include tearing of tendon fibers, regeneration with fibroblast proliferation, myxomatous
degeneration, and capillary proliferation without any inflammatory response (Roels et al. 1978, 
Karlsson et al. 1991, Colosimo and Bassett 1990, Bassett et al. 1980, Khan et al. 1998). However,
these observations are from patients with disabling symptoms (grade IIIb), among whom 
conservative treatment methods have failed. The correlation between ultrasound findings and 
histopathology in patients with patellar tendinopathy has been studied by Khan et al. (1996). In 
this study, 28 knees diagnosed with patellar tendinopathy planned for surgical treatment
underwent an ultrasonographic examination. Control biopsies were taken from 39 cadaver knees. 
All knees diagnosed with patellar tendinopathy had an ultrasonographically abnormal zone at the 
proximal patellar tendon and histopathological examination revealed mucoid degeneration in all 
these tendons and in three of 39 (8%) in the cadaver knees. This study correlates the histological
findings in biopsies from patients clinical diagnosed with patellar tendinopathy combined with 
simultaneous typical ultrasonographic findings, and describes a very close correlation between 
this subgroup of athletes with patellar tendinopathy and a specific histopathologic finding 
(mucoid degeneration). All the previous mention studies on histopathology present results from a 
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cohort of patients with disabling symptoms (grade IIIb), among whom conservative treatment 
methods have failed. 
However, to our knowledge, there is no available information on the histopathological changes in 
patients with Roels' grade I, II or IIIa disease. In spite of lack of this information, attempts have 
been made to correlate ultrasound changes and anatomical findings to the clinical staging of the 
disease (Fritschy and DeGautard 1988, Jerosch et al. 1990). Jerosch and Schröder (1990) 
suggested that a relationship exists between the severity of the pathological changes and certain 
ultrasound characteristics. More serious disease is assumed to be associated with wide-spread 
thickening of the tendon, echoic changes and surface irregularities. The correlations made in 
these studies are based on assumptions since the ultrasound findings are not correlated to 
corresponding histopathologic findings in the same individuals. In the present study we found no 
correlation between the presence of surface changes suggesting paratenon pathology, and either 
the presence of symptoms or the degree or duration of symptoms. This suggests that paratenon 
changes do not necessarily constitute a sign of more serious clinical disease. 
Several studies have shown near-perfect correlation between preoperative ultrasound changes
and surgical findings (Raatikainen et al. 1994, Orava et al. 1986, Kälebo et al. 1991, King et al. 
1990, Karlsson et al. 1992). However, as these studies were carried out in a selected patient
group, i.e., almost all of them had disabling symptoms (grade IIIb) who did not respond to non-
operative treatment, the results should be interpreted carefully when applied to other patient
populations. Indeed, the results of the present study and that of Myllymäki et al. (1990) show that 
the correlation between ultrasound changes and symptoms is weak among athletes with less 
serious symptoms. Karlsson et al. (1992) studied 91 patients with grade III symptoms and 
hypoechoic changes on ultrasound examination. When the patients were grouped according to 
the length of the hypoechoic zones, only 6.6% of the patients with changes of <10 mm needed 
surgical treatment, whereas 38.5% of those with changes of >20 mm subsequently needed
surgical treatment (Karlsson et al. 1992). This suggests that the length of the hypoechoic zone 
may be a significant factor in planning treatment. However, we did not find any correlation
between clinical staging and the length of the hypoechoic changes, nor could we find any 
relationship with the duration of symptoms. Since there appears to be a correlation between the 
size of the hypoechoic area and the effect of nonoperative treatment, but no correlation between 
size and clinical staging or duration of symptoms, this may be one reason why the relationship
between clinical stage and effect of non-operative treatment may be difficult to predict. As a 
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conclusion from the present study specific ultrasound findings could neither be used to predict 
the clinical grade of the disease, nor the duration of symptoms. 
When comparing normal tendons and tendons with symptoms of jumper's knee, we found a 
significant difference between the asymptomatic and symptomatic players in antero-posterior 
tendon thickness, particularly in the proximal part of the tendon, the location where most of the 
echoic changes were observed. Several studies involving surgery have found that in the majority
of the cases the pathological process is localized in the proximal posterior part of the tendon
(Roels et al. 1978, Ferretti 1986, Karlsson et al. 1991, Colosimo and Bassett 1990, Bassett et 
al.1980). MRI studies have shown that the antero-posterior diameter of the normal tendons
increases slightly from proximal to distal (el-Khoury et al. 1992). Since stress/strain resistance is 
correlated to the cross-sectional area, this may explain why the pathological process usually starts 
in the proximal part of the tendon. The length of tendon fascicles varies with longer anterior 
fascicles than the corresponding posterior fascicles since the anterior bundles are attached more 
proximal to the patella and more distal to the tibia than the corresponding posterior bundles 
(Basso et al. 2001). For a same amount of elongation, the shorter posterior fascicles strain more 
than the longer anterior fascicles (strain=elongation/gauge length) (Basso et al. 2002), which may 
explain why the pathological process is localized to the posterior part of the tendon. 
No difference in the tendon length or the modified Insall-Salvati index could be detected 
between symptomatic and asymptomatic groups of knees. This suggests that players with longer
tendons are not predisposed to jumper's knee in contrast to Kujala et al.(1986, 1987), who 
reported a significantly higher proportion with patella alta among those with jumper's knee 
compared to controls. However, their reports included much fewer volleyball players in the 
control groups than in the patient groups, and this fact may have skewed their results and 
reduced the external validity of their studies. 
Innervation
Results
Patient characteristics. The mean age was 30 years (24-34 years, n=10) in the patient group and 29 
years (19-43 years, n=10) in the control group. In the patient group, the mean number of years 
participating in organized training was 17 (10-28 yrs, n=10), and the mean number of total
training hours per week was 14 (6-24 h, n=10). The mean VISA score was 42 (15-65, n=10), and 
the mean duration of symptoms was 36 months (5-120 months, n=10). 
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Microscopy
The morphologic appearance of the painful tendons in the tendon proper differed significantly 
compared to the controls. The proper tendinous tissue exhibited signs of tendinosis (collagen 
degeneration, fiber disorientation, hypercellularity, angiogenesis, and absence of inflammatory 
cells) in all but one of the patients, whereas only a few of the controls exhibited early signs of 
tendinosis.
Semi-quantitative assessment of tenocyte morphology and of angiogenesis was performed 
according to the Bonar scale (Cook et al. 2004). Tenocyte changes occurred in all but one of the 
painful tendons, whereras only 5 of 14 controls exhibited these changes (p=0.006). Angiogenesis,
considered to be the last histological sign of tendinopathy (Cook et al. 2004), was found in 4 of 
11 painful tendons, but in none of the controls (p=0.038).
Immunohistochemistry
Overall, the subjective immunohistochemical assessment confirmed the morphologic appearance. 
However, it also provided more detailed information about sensory (SP) and sympathetic (TH) 
nerve fiber occurrence in the patellar tendon. Thus, the majority of the painful tendons exhibited 
an increased number of nerve fibers positive to SP and notably decreased levels of TH. 
Sensory nerves
Closer subjective analyses showed that the increased number of SP-positive fibers in the painful 
tendons occurred mainly as thin, varicose, non-vascular nerve terminals within the tendon
proper. Notably, these SP-positive nerves in the painful tendons were found over a larger area, 
more spread out within the tendon than in the controls. The SP positive nerve fibers seen as free 
nerve endings interspersed between the proper collagen fibers, often accompanying the loose 
connective tissue ingrowth within the tendon proper of the painful tendons. Contrary to what 
one might have expected, no differences were noted between the groups regarding the small 
subpopulation of vascular SP-positive fibers. In both groups, SP was regularly seen in larger 
nerve bundles. 
Sympathetic nerves 
Subjective analyses demonstrated not only a great difference in the occurrence of TH-expressing 
nerve fibers between patients and controls, but also in their morphological distribution. In both 
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groups, TH-positive nerves were present as free nerve endings throughout the tendon proper
but, unlike the sensory nerves, the majority of the TH-nerves were distinctively related to the 
blood vessels. In the patients, there was a distinct decrease in the occurrence of TH-positive 
nerves. Some TH-positive free nerve endings were still seen, but the vessel-related TH nerves 
were significantly diminished in the patients.
General nerve occurrence 
The neuronal localisation of SP- and TH-staining was confirmed by positive immunoreactivity 
for PGP, a general nerve marker. The subjective analyses of PGP showed a higher nerve fiber 
occurrence in the chronic pain group compared to the controls. Nerves existed both as vascular
and non-vascular free nerve endings and in larger bundles. 
Semi-quantitative immunohistochemistry
Computerized image analysis of SP, TH and PGP expression showed similar differences in 
occurrence as assessed subjectively, although all results were not statistically significant. The 
occurrence of SP was 22% (p=0.567) and that of PGP 54% (p=0.098) higher in the chronic
painful tendons than in the controls. The occurrence of TH in the chronic painful tendons was 
53% lower than in the controls (p =0.018). 
Discussion
This study demonstrates that nerve fibers expressing sensory (SP) and sympathetic 
neuromediators (TH) appear to differ between patients with painful patellar tendinopathy and 
healthy controls. Most notably, an increased number of SP-positive non-vascular nerve endings 
and a vascularly related decrease in TH were seen.
The sensory neuropeptide, substance P, has a strong proinflammatory function, such as increased 
angiogenesis and vasopermeability, in addition to its role in nociception. The increased number
of sensory nerves seen as sprouting free nerve endings in the painful tendons may, at least partly, 
explain the pain. The fact that the increased number of SP fibers was not seen around blood 
vessels was somewhat surprising, since one might have expected a strong connection, similar to 
that seen in healing tendons. Instead, the existence of free nerve endings indicated that the main 
function of SP in tendinopathy is nociceptive rather than vasoactive.
51
Results and discussion
The reduction in TH, vascular noradrenaline, suggests a role in pain modulation. Noradrenaline 
as a peripheral and vascular pain modulator is a topic of ongoing research. Notably, a similar
pattern of decreased vascular TH and increased free SP positive nerve fibers is seen in patients 
with painful rheumatoid arthritis (Straub et al. 2002). 
The mean VISA score of 42 combined with a mean symptom duration of three years and
histopathological findings characteristic of severe tendinosis mean that the patient group is 
characterized by chronic and severe complaints of patellar tendinopathy.
Variation between biopsies was high, and the semi-quantitative analysis confirmed only one of 
the three subjective analyses of the neuromediators in question. However, the trends all pointed 
in the same direction. The semi-quantitative method only takes the fields with highest density of 
immunofluorescence into account, thus overlooking histological differences, such as extensive 
nerve sprouting. The semi-quantitive analysis should therefore only be regarded as a complement
to the subjective analysis.
In conclusion, the results demonstrate a differentiation in the sensory and sympathetic
neuromediator pattern in painful tendinopathic tendons. The dominance of nonvascular SP nerve
endings, as well as the decrease of the anti-nociceptive modulator, noradrenaline, suggests a 
pathophysiological regulation of pain. These neuropeptides, known to be essential for normal 
healing, exhibit a disturbed balance that may contribute to the degenerative processes of 
tendinopathy.
Apoptosis
Results
Clinical characteristics. The mean age was 30 years (24-34 years, n=23) in the patient group and 29 
years (19-43 years, n=11) in the control group. In the patient group, the mean number of years 
participating in organized training was 17 (10-28 yrs, n=23), and the mean number of total
training hours per week was 14 (6-24 h, n=23). The mean VISA score was 42 (15-65, n=23), and 
the mean duration of symptoms was 36 months (5-120 months, n=23). 
Light microscopic appearance. Biopsies from patients with a clinical history of tendon pain 
consistently revealed tendinosis, including areas of hypocellularity, as well as neovascularization 
with intimal hyperplasia, and collagen disarray and degeneration. Increased amounts of 
52
Results and discussion
glycosaminoglycan were localized to areas of fibrocartilagenous metaplasia or to the neointima of 
the vessel. Inflammatory cells were virtually absent.
Apoptosis in normal and overused tendons. Apoptotic tenocytes were identified using all three methods 
(F7-26, propidium iodide, caspase-3) both in normal and pathological tendon, and each method 
showed that apoptosis represented a small minority of total cell counts (< 1%). Apoptosis was 
predominantly found in fibroblast-like cells in the tendon proper. Clusters of 5 to 10 apoptotic 
cells were observed in the tendinosis samples, compared to scattered or no cells in the controls.
The number of apoptotic cells per unit area (4.5 mm2) was 0.91 ± 0.81 in tendinosis samples and 
0.21 ± 0.21 in controls (p=0.026). There were more areas with apoptotic cells in the tendinosis
tissue (3.7 ± 0.20 vs 1.9 ± 1.2, p=0.006). In addition, fields from tendinosis patients that 
displayed positive staining had more apoptotic cells than positive fields from controls (3.1 ± 2.2 
vs 1.5 ± 0.89, p=0.006). Although the tendinosis samples displayed increased numbers of 
fibroblastic cells (52 ± 32 nuclei/mm2 vs 31 ± 16 nuclei/mm2, p=0.021), the apoptotic index was 
higher (0.42 ± 0.38 % vs 0.17 ± 0.16 %, p =0.014).
Discussion
The results showed a significantly higher number of apoptotic cells per unit area and a 
significantly higher apoptotic index in biopsies from the patellar tendons in patients with patellar 
tendinopathy compared with controls. The caspases are members of a family of cysteine 
proteases with a sequential activation and amplification system eventually causing apoptosis 
(Salvesen 2002). Since caspase-3 is one of the terminal proteins in the caspase activation system
(Boatright and Salvesen 2003), this finding denotes an increased apoptotic activity in the patellar 
tendon in patients with patellar tendinopathy compared with controls.
The caspases are synthesized as inactive zymogens and it is essential that the caspases remain 
inactive until the apoptotic signal is received (Boatright and Salvesen 2003). Apoptosis is typically 
triggered by a variety of cellular stresses including ischemia-reperfusion and oxidative stress, loss 
of extracellular matrix contact, excessive cytosolic calcium, cytoskeletal disruption, mechanical
trauma, and others. Alternatively, disappearance of excessive fibroblasts during tissue remodelling 
is a normal, physiological response (Grinnell et al. 1999). In tendinopathy, the mechanisms
underlying apoptosis and caspase-3 activation, and whether or not it represents a pathological or 
a physiological process, are not currently known. How early in the pathogenesis of tendinosis 
apoptosis arises remains an important question. 
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The link between mechanical loading conditions and the pathophysiological response in 
tendinopathy is obscure, and currently there is insufficient evidence to provide a direct 
explanation for the possible connection between the loading pattern and the in vivo pathological 
response (Scott et al. 2005). Paper III and Paper IV show that volleyball players with jumper’s 
knee have better jumping ability and power generation than players who do not report symptoms 
from their tendons, presumably because they subject their knee extensors to higher loads when 
jumping and landing. Also, prevalence is higher in sports that require frequent jumping as shown 
in Paper I, and among athletes who train more (Ferretti et al.1984). Thus, there is reason to 
believe that there is a connection between the tendon loading pattern and the pathology within 
the tendon substance. In a study by Yuan et al. (2002), excessive apoptosis was observed at the 
edge of torn rotator cuff tendons in elderly patients compared with controls. This has led to the 
proposal that tendinosis may begin as a degenerative process involving tenocyte death (Yuan et 
al. 2003). In support of this model, Skutek et al. (2003) suggested that mechanical stretching of 
tendon fibroblasts activates cell signaling pathways leading to apoptosis. However, once ruptured 
the supraspinatus tendon would likely not receive excessive tensile loads, therefore other 
mechanisms such as oxidative stress, hypoxia, or remodelling may predominate in later stages. In 
another study, Barkhausen et al. (2003) found that different repetitive cyclic longitudinal stress
patterns resulted in different cellular reactions dependent on the strength of the applied stress. 
Repetitive stress applied during one day stimulated both proliferation and apoptosis (Barkhausen 
et al. 2003). Our data show the number of tenocytes was increased overall, but there were also 
discrete areas of apoptosis and hypocellularity, suggesting that death and proliferation may be 
occurring simultaneously in response to repetitive loading, similar to the finding by Barkhausen et 
al. (2003). 
One of the consistent histological findings in biopsies in tendons from patients with patellar 
tendinopathy is the scarcity of inflammatory cells (Karlsson et al. 1991, Khan et al. 2000a, 
Martens et al. 1982). In a study by Alfredsson et al. (2003), cDNA arrays and real-time 
quantitative polymerase chain reaction technique were used to study tendinosis and control tissue 
samples. Several cytokines and cytokine receptors were not upregulated, suggesting the absence 
of an extrinsic inflammatory process in chronic painful Achilles tendinosis. 
If the primary pathology were a partial rupture, one might have expected the presence of an 
inflammatory response since this is the case with acute, total tendon ruptures. However, in time 
cellular inflammation would be expected to diminish and evolve into a typical post-inflammatory 
reparative response as seen in tendons and other connective tissues (increased
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glycosaminoglycans and collagen synthesis, neovascularisation, hypercellularity and apoptosis of 
fibroblasts). In keeping with this picture, the extent of cell death observed in the current study
would not be expected to trigger an inflammatory response, particularly given the poor 
vascularisation of tendons. 
This study contributes a novel insight toward understanding the pathology of tendinosis, namely, 
that there is evidence of increased apoptosis in association with degenerate, non-ruptured tendon 
compared to controls. However, there remain several limitations that must temper conclusions. 
Firstly, our cross-sectional study sheds no light on whether apoptosis preceded or followed the 
development of tendinosis. Secondly, our data were obtained in young sports people with 
chronic patellar tendinosis – we may not extend our conclusions beyond this population as yet.
55
A model for the causation of patellar tendinopathy
A model for the causation of patellar tendinopathy
Tissue homeostasis model 
Dye (2005) has presented a model on the pathophysiology of patellofemoral pain. In this model 
he states that certain high loading conditions may induce loss of tissue homeostasis by exceeding
the safe load acceptance capacity of the tissue, leading to symptomatic damage.
Figure 6. This figure describes the relationship between structural adaptation and the frequency and loading of a joint. The 
figure is reproduced from Dye (2005). 
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In this model, Dye (2005) describes a zone of load acceptance called “zone of homeostasis”. By 
increasing the load and frequency beyond this limit the tissue will enter a zone of physiological 
overload, where there is gradual adaptation of tissue properties to the increased load. However, if 
even greater load and/or frequency is applied, structural damage will occur. The zone between 
subphysiological underload and supraphysiological overload is termed “the envelope of 
function”.
Dye’s model for patellofemoral pain assumes that the main causative factors are load and 
frequency. This seems to be the case for patellar tendinopathy, as well. Early epidemiological 
studies on volleyball players have shown that training frequency correlates positively with the 
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prevalence of patellar tendinopathy (Ferretti et al. 1984, Ferretti 1986). Moreover, sports 
characterized by high demands on speed and power have a higher prevalence of patellar 
tendinopathy (Paper I). When groups of athletes from the same sports and teams were 
compared, differences in total or jump training volume could be detected between asymptomatic 
and symptomatic athletes, at least in some cases (Paper I). However, in Paper II we found no 
difference between groups in the total amount of specific volleyball training. It also follows from 
the results that there are asymptomatic athletes who report very high training volumes and 
symptomatic athletes who train much less. Thus, the model above does not fully explain why 
some athletes develop tendinopathy and other athletes from the same team do not, despite being 
exposed to the same training load and frequency. Other factors must also play a significant role, 
either alone or by modifying tendon load or load tolerance. 
Risk factor model 
In order to account for interactions between different internal and external risk factors, as well as 
to relate these to the mechanisms by which the injuries occur, a dynamic multicausal model has 
been developed (Meeuwisse 1994, Bahr and Holme 2003, Bahr and Krosshaug 2005). However,
this model has mainly been applied to describe the etiology of injuries with a sudden onset,
resulting from a specific, identifiable event. Clinical experience suggests that such an acute trauma 
rarely can be recalled in cases of patellar tendinopathy, but that symptoms develop gradually over 
weeks and months. Thus, when applying the Meeuwisse model to explain the etiology of overuse 
injuries, some modifications are necessary. Mainly, this relates to the description of the injury 
mechanisms, the final link in the chain of leading to injury. In the case of overuse injuries, the 
injury mechanism is represented by the training and competition program the athlete has
followed during the period the injury has developed, keeping in mind that pathology may even 
develop within the tissue long before symptoms occur. Thus, factors which describe the tendon 
loading conditions during this period, such as training volume, training frequency and type,
changes in the training program, type of sport, need to be characterized to describe the injury
mechanisms for overuse injuries. Different intrinsic and extrinsic factors can affect load and load 
tolerance, and these interactions must therefore be accounted for.
Based on the available evidence, the causes of patellar tendinopathy can be summarized as shown 
in Figure 7. 
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Figure 7. A dynamic, multifactorial model of the etiology of patellar tendinopathy.
Male gender is an intrinsic risk factor, because the prevalence of current jumper’s knee in female 
handball and female soccer was 2.4 times lower compared with the corresponding male sports 
(Paper I). Body weight appears to be an intrinsic risk factor, because athletes diagnosed with 
jumper’s knee weighted significantly more compared with asymptomatic athletes (Paper I and 
IV). In the biomechanical studies (Paper III and VI), players with jumper’s knee performed better 
in standardized series of jump and power tests compared with the control groups. In Paper IV 
we found a correlation between the takeoff technique and jumper’s knee. The right knee was 
affected twice as often as the left knee. The majority of the players used a right-left step-close 
takeoff technique, and none of the players reportedly preferred the right leg when landing after 
the attack. In fact, 20 of the 22 players with current jumper's knee on the right side used a right-
left takeoff technique. This means that the leg doing the eccentric work is mostly affected. This 
finding may be related to the observations in Paper III, where the patient group appeared to be 
more effective in counter-movement jumps compared with the controls. Better eccentric 
performance during the decelerating part of the step-in will result in a better jumping ability, and 
consequently, higher tendon load when jumping. 
Genetic factors are probably also of importance as shown by Mokone et al. (2006), who found 
that individuals with an A2 allele of the ơ1 type V collagen gene (COL5A1) were less likely to 
develop symptoms of chronic Achilles tendinopathy. However, the authors state that this 
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association does not prove a causal relationship, since there may be other closely linked genes 
involved (Mokone et al. 2006). Age was not a significant risk factor for jumper’s knee in any of 
the present studies.
Ferretti et al. (1984) suggested a positive correlation between the hardness of the floor and the 
prevalence of jumper’s knee among volleyball players. In line with this, it has recently been 
shown that the prevalence of jumper’s knee among elite beach volleyball players playing on sand 
is only 9%, considerably lower than for indoor volleyball players (Bahr and Reeser 2003). Thus, 
the hardness of the floor can be regarded as an extrinsic risk factor for jumper’s knee. Other 
suggested risk factors for jumper’s knee have not been well documented yet.
Inciting event
In chronic overload injuries there is not a well defined inciting event. However, Paper I shows a 
small, but significantly higher training volume in players with symptoms of jumper’s knee 
compared to asymptomatic controls. Volleyball players with jumper’s knee reportedly also trained 
more with weights (Paper I and IV). The overall prevalence of current and previous jumper’s 
knee was significant higher in sports characterized by ballistic movements, speed and power 
(Paper I). A combination of all these factors may—in an athlete predisposed by intrinsic and 
extrinsic risk factors—result in structural tendon damage. Thus, the loading characteristics
determined by the training and competition program may be regarded as the inciting event in 
jumper’s knee. 
In the model described above, internal and external risk factors act together to make the 
individual susceptible to tendinopathy. For example, a volleyball player with a specific jumping 
technique will need to perform a certain amount of specific training on a specific floor hardness 
to develop tendinopathy. In our experience, the first symptoms of jumper’s knee often occur 
after a period with increased training loads in a young athlete who is selected to a team or a 
training camp at a higher level of play. These talented young athletes may, from one week to the 
next, move from a relatively “safe” training environment—for example, practice two to three 
days a week, no weight lifting—to an elite club or sports school that practices daily, including 
intensive weight and jump training. Talented athletes are also likely to possess superior jumping 
ability which, when coupled with sudden increases in strength, muscle mass, and training load, 
further amplifies their risk of developing tendinopathy. In this setting the increased training load 
may be regarded as the inciting event, bringing the tendon tissue out of the envelope of function, 
ending up with structural damage. 
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Mechanotransduction
However, the link between loading conditions and structural damage is obscure. Koskinen et al. 
(2004) have shown that physical activity can influence the activity of local matrix
metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in vivo, and suggest that this may 
be of importance in extracellular adaptation to exercise in tendon tissue. In a study by Miller et al. 
(2005), they found an increased synthesis of collagen in the patellar tendon after a single acute 
bout of strenuous, non-damaging exercise. They hypothesize that this increased collagen 
production may be due to some common signalling pathway transducing the mechanical stimuli 
into anabolic events (Miller et al. 2005). Langberg et al. (2006) showed that patients with Achilles 
tendinosis treated with 12 weeks of eccentric training increased their collagen synthesis rate, but 
the collagen metabolism in healthy controls was not affected by eccentric training. They suggest 
that this might indicate an inadequate adaptation of tissue strength to the activity level in 
tendinosis, with a subsequent tissue injury (Langberg et al. 2006). Olesen et al. (2006) have shown 
that loading of the plantaris tendon in rats resulted in upregulation of IGF-1 and procollagen. 
They suggest that the IGF-1 system probably is involved in regulation of the collagen synthesis in 
tendon in response to mechanical loading (Olesen et al. 2005). Lavagnino et al. (2005) have 
shown that tendon cells could establish an internal cytoskeletal tension through interactions with 
the extrecellular environment. Alterations in this tension could control the expression of both 
catabolic and anabolic genes (Lavagnino et al. 2005). Studies on isolated tendon cells in vitro have 
shown that stress deprivation results in up-regulation of interstitial collagenase, while application 
of a tensile load inhibits mRNA expression of interstitial collagenase, probably through the same 
cytoskeletally based mechanotransduction mechanism (Arnoczky et al. 2002). In a study by
Mokone et al. (2005), they found that persons with variants of the tenacin-C gene with 12 and 14 
guanine-thymidine repeats appeared to have a 6-fold risk of developing Achilles tendon injuries. 
Since mechanical signals can alter the synthesis of tenacin-C (Chiquet 1999), and tenacin-C can 
regulate cell-matrix interactions, the author speculate if this protein may be of importance in a 
possible apoptotic model of tendinopathy (Mokone et al. 2005). Arnoczky et al. (2002) have also 
shown, at the cellular level, that cyclic strain induces activation of stress-activated protein kinases 
(SAPK), possibly by a calcium-dependent mechanotransduction pathway. Since SAPK activation 
are important upstream regulators of the apoptosis cascade in different cell lines, they speculate if 
this mechanotransduction pathway may induce apoptosis and be part of the etiology in tendon 
overload injuries (Arnoczky et al. 2002). Scott et al. (2005) have shown that high-strain
mechanical loading rapidly induced tendon apoptosis in an ex vivo rat tibialis anterior model. In 
Paper VI, we found excessive apoptosis in tendon biopsies from patients with patellar 
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tendinopathy compared with controls. This means that both at the molecular, cellular and 
isolated muscle-tendon level, as well as in vivo, there is reason to suggest a connection between 
biomechanical factors and specific anabolic and catabolic biologic responses, among them 
excessive apoptosis, through a mechanotransduction pathway.
In conclusion, the present model connects the loading pattern and specific extrinsic and intrinsic 
factors which can modify load or load tolerance to specific histopathological findings through a 
mechanotransduction pathway, ending up with structural damage and pain. The different 
anabolic and catabolic processes may be specific to the different loading conditions, initially 
probably in a reversible way. Understanding these relationships may be key factors to establish
effective preventive measures.
Conclusions
Based on the results of the papers presented in this thesis, the conclusions are as follows: 
1. The overall prevalence of current and previous jumper’s knee was significantly higher in 
sports characterized by ballistic movements, speed and power. The condition is in most cases 
chronic, and athletes report significant symptoms and disability, particularly related to sport. 
2. The prevalence of current jumper’s knee among males was 2.4 times higher than females in 
comparable sports. 
3. Athletes diagnosed with jumper’s knee weighted significantly more compared with 
asymptomatic athletes, while age was not identified as a significant risk factor for jumper’s 
knee.
4. Training volume was somewhat higher in players with symptoms of jumper’s knee than 
controls. Also, players with jumper’s knee reportedly trained more with weights. 
5. Players with jumper’s knee performed better in standardized series of jump and power tests
compared with controls. 
6. The prevalence of ultrasound changes in the patellar tendon was high among elite volleyball
players, approximately 50%, but the correlation between symptoms and ultrasound changes
was low. 
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7. Nerve fibers expressing sensory (SP) and sympathetic neuromediators (TH) appear to differ 
between patients with painful patellar tendinopathy and healthy controls. An increased 
number of SP-positive non-vascular nerve endings and a vascularly related decrease in TH 
were seen in patients. 
8. Biopsies from the patellar tendons in patients with patellar tendinopathy displayed evidence 
of increased apoptosis than healthy controls. 
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